US20230372592A1 - Antimicrobial Catheter Assemblies and Methods Thereof - Google Patents
Antimicrobial Catheter Assemblies and Methods Thereof Download PDFInfo
- Publication number
- US20230372592A1 US20230372592A1 US18/230,061 US202318230061A US2023372592A1 US 20230372592 A1 US20230372592 A1 US 20230372592A1 US 202318230061 A US202318230061 A US 202318230061A US 2023372592 A1 US2023372592 A1 US 2023372592A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- copper
- antimicrobial coating
- hub
- antimicrobial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 217
- 238000000034 method Methods 0.000 title claims description 13
- 238000000429 assembly Methods 0.000 title description 4
- 230000000712 assembly Effects 0.000 title description 4
- 239000011248 coating agent Substances 0.000 claims abstract description 178
- 238000000576 coating method Methods 0.000 claims abstract description 178
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 120
- 229910052802 copper Inorganic materials 0.000 claims abstract description 120
- 239000010949 copper Substances 0.000 claims abstract description 120
- 239000004599 antimicrobial Substances 0.000 claims abstract description 24
- 229910052751 metal Inorganic materials 0.000 claims abstract description 24
- 239000002184 metal Substances 0.000 claims abstract description 24
- 239000002131 composite material Substances 0.000 claims abstract description 16
- 238000005260 corrosion Methods 0.000 claims abstract description 10
- 230000007797 corrosion Effects 0.000 claims abstract description 10
- 230000001737 promoting effect Effects 0.000 claims abstract 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 38
- -1 polyethylene Polymers 0.000 claims description 20
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 19
- 239000010931 gold Substances 0.000 claims description 19
- 229910052763 palladium Inorganic materials 0.000 claims description 19
- 229910052737 gold Inorganic materials 0.000 claims description 14
- 238000000151 deposition Methods 0.000 claims description 13
- 230000008021 deposition Effects 0.000 claims description 13
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 12
- 239000010936 titanium Substances 0.000 claims description 12
- 229910052719 titanium Inorganic materials 0.000 claims description 12
- 229920000642 polymer Polymers 0.000 claims description 10
- 229920001296 polysiloxane Polymers 0.000 claims description 10
- 239000004800 polyvinyl chloride Substances 0.000 claims description 10
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 10
- 229910000881 Cu alloy Inorganic materials 0.000 claims description 9
- 239000004698 Polyethylene Substances 0.000 claims description 9
- 239000004743 Polypropylene Substances 0.000 claims description 9
- 238000005229 chemical vapour deposition Methods 0.000 claims description 9
- 238000004070 electrodeposition Methods 0.000 claims description 9
- 239000011159 matrix material Substances 0.000 claims description 9
- 238000005240 physical vapour deposition Methods 0.000 claims description 9
- 229920000515 polycarbonate Polymers 0.000 claims description 9
- 239000004417 polycarbonate Substances 0.000 claims description 9
- 229920000573 polyethylene Polymers 0.000 claims description 9
- 229920001155 polypropylene Polymers 0.000 claims description 9
- 229920002635 polyurethane Polymers 0.000 claims description 9
- 239000004814 polyurethane Substances 0.000 claims description 9
- 229910001020 Au alloy Inorganic materials 0.000 claims description 5
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052718 tin Inorganic materials 0.000 claims description 4
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 4
- 229910052721 tungsten Inorganic materials 0.000 claims description 4
- 239000010937 tungsten Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000011135 tin Substances 0.000 claims description 3
- 239000012530 fluid Substances 0.000 description 47
- 230000037361 pathway Effects 0.000 description 29
- 239000000126 substance Substances 0.000 description 9
- 230000000813 microbial effect Effects 0.000 description 8
- 238000004891 communication Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000011109 contamination Methods 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 210000003462 vein Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 229910000510 noble metal Inorganic materials 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009713 electroplating Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- 229910001369 Brass Inorganic materials 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- 239000005750 Copper hydroxide Substances 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- RAOSIAYCXKBGFE-UHFFFAOYSA-K [Cu+3].[O-]P([O-])([O-])=O Chemical compound [Cu+3].[O-]P([O-])([O-])=O RAOSIAYCXKBGFE-UHFFFAOYSA-K 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 238000005844 autocatalytic reaction Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000010951 brass Substances 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002322 conducting polymer Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- 229910001956 copper hydroxide Inorganic materials 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- QYCVHILLJSYYBD-UHFFFAOYSA-L copper;oxalate Chemical compound [Cu+2].[O-]C(=O)C([O-])=O QYCVHILLJSYYBD-UHFFFAOYSA-L 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 229960004643 cupric oxide Drugs 0.000 description 1
- 229940045803 cuprous chloride Drugs 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 238000005137 deposition process Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- FWBOFUGDKHMVPI-UHFFFAOYSA-K dicopper;2-oxidopropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O FWBOFUGDKHMVPI-UHFFFAOYSA-K 0.000 description 1
- ALKZAGKDWUSJED-UHFFFAOYSA-N dinuclear copper ion Chemical compound [Cu].[Cu] ALKZAGKDWUSJED-UHFFFAOYSA-N 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000007737 ion beam deposition Methods 0.000 description 1
- 238000001659 ion-beam spectroscopy Methods 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 229910001112 rose gold Inorganic materials 0.000 description 1
- 239000010939 rose gold Substances 0.000 description 1
- 238000005488 sandblasting Methods 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000005494 tarnishing Methods 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/10—Inorganic materials
- A61L29/106—Inorganic materials other than carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0009—Making of catheters or other medical or surgical tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0045—Catheters; Hollow probes characterised by structural features multi-layered, e.g. coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0097—Catheters; Hollow probes characterised by the hub
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M39/0606—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof without means for adjusting the seal opening or pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0056—Catheters; Hollow probes characterised by structural features provided with an antibacterial agent, e.g. by coating, residing in the polymer matrix or releasing an agent out of a reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/062—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof used with a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
- A61M2039/066—Septum-like element
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M2039/1072—Tube connectors; Tube couplings with a septum present in the connector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0205—Materials having antiseptic or antimicrobial properties, e.g. silver compounds, rubber with sterilising agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0238—General characteristics of the apparatus characterised by a particular materials the material being a coating or protective layer
Definitions
- CVCs central venous catheters
- drugs e.g., chemotherapeutic agents
- CRS catheter-related sepsis
- Replacing such catheters at frequent intervals is one potential solution to CRS, but frequently replacing the catheters often results in replacing sterile catheters that need not to be replaced—and additional catheterization carries with it its own risks.
- antimicrobial catheters are needed to prevent bacteria colonies that can migrate into the blood. Disclosed herein are antimicrobial catheter assemblies and methods thereof that address the foregoing.
- an antimicrobial catheter assembly including, in some embodiments, a hub, a catheter tube connected to the hub, at least one extension leg connected to the hub, and a non-eluting antimicrobial coating on an internal surface of the catheter assembly, an external surface of the catheter assembly, or both the internal and external surfaces of the catheter assembly.
- the hub includes at least one hub lumen defining a corresponding hub portion of a fluid pathway through the catheter assembly.
- the catheter tube includes at least one catheter-tube lumen defining a corresponding catheter-tube portion of the fluid pathway through the catheter assembly.
- the extension leg includes an extension-leg lumen defining a corresponding extension-leg portion of the fluid pathway through the catheter assembly.
- the antimicrobial coating is a composite of two or more layers.
- the antimicrobial coating includes a copper-based layer between a corrosion-preventing layer and the internal or external surface of the catheter assembly, an adhesion-promoting layer between the copper-based layer and the internal or external surface of the catheter assembly, or a combination thereof.
- the adhesion-promoting layer includes an adhesion-promoting metal.
- the adhesion-promoting metal promotes adhesion of the copper-based layer to a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone.
- the adhesion-promoting metal is selected from gold, palladium, and titanium.
- the copper-based layer is substantially pure copper, a copper alloy of copper and gold, palladium, zinc, or tin, or a copper matrix composite of copper and tungsten.
- the corrosion-preventing layer includes a corrosion-resistant metal selected from gold, palladium, and titanium.
- the antimicrobial coating includes two layers, the two layers being the adhesion-promoting layer and the copper-based layer.
- the antimicrobial coating includes two layers, the two layers being the copper-based layer and the corrosion-preventing layer.
- the antimicrobial coating includes three layers, the three layers being the adhesion-promoting layer, the copper-based layer, and the corrosion-preventing layer.
- the antimicrobial coating is on the internal surface of the catheter assembly including the hub lumen defining the corresponding hub portion of the fluid pathway through the catheter assembly.
- the antimicrobial coating is on the internal surface of the catheter assembly including the extension-leg lumen defining the corresponding extension-leg portion of the fluid pathway through the catheter assembly.
- the antimicrobial coating is on the external surface of the catheter assembly including an abluminal surface of the extension leg between at least proximal and distal end portions of the extension leg.
- the antimicrobial coating is on the external surface of the catheter assembly including an abluminal surface of a transcutaneous region of the catheter tube.
- the antimicrobial catheter assembly further includes at least one Luer connector connected to the extension leg.
- the antimicrobial coating is on the internal surface of the catheter assembly including an internal surface of the Luer connector in fluid communication with the fluid pathway, an external surface of the catheter assembly including an external surface of the Luer connector, or a combination thereof.
- an antimicrobial catheter assembly including, in some embodiments, a bifurcated hub, a catheter tube connected to the hub, a pair of extension legs connected to the hub, a pair of Luer connectors connected to the extension legs, and a non-eluting antimicrobial coating on an internal surface of the catheter assembly, an external surface of the catheter assembly, or both the internal and external surfaces of the catheter assembly.
- the hub includes a pair of hub lumens defining corresponding hub portions of a pair of fluid pathways through the catheter assembly.
- the catheter tube includes a pair of catheter-tube lumens defining corresponding catheter-tube portions of the pair of fluid pathways through the catheter assembly.
- Each extension leg of the pair of extension legs includes an extension-leg lumen defining a corresponding extension-leg portion of the pair of fluid pathways through the catheter assembly.
- the antimicrobial coating is a composite of two or more layers.
- the antimicrobial coating includes a copper-based layer between a corrosion-preventing layer and the internal or external surface of the catheter assembly, an adhesion-promoting layer between the copper-based layer and the internal or external surface of the catheter assembly, or a combination thereof.
- the adhesion-promoting layer promotes adhesion of the copper-based layer to a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone.
- the adhesion-promoting layer includes a metal selected from gold, palladium, and titanium.
- the copper-based layer is substantially pure copper, a copper alloy of copper and gold, palladium, zinc, or tin, or a copper matrix composite of copper and tungsten.
- the corrosion-preventing layer includes a corrosion-resistant metal selected from gold, palladium, and titanium.
- the antimicrobial coating includes two layers.
- the two layers are either the adhesion-promoting layer and the copper-based layer or the copper-based layer and the corrosion-preventing layer.
- the antimicrobial coating includes three layers.
- the three layers are the adhesion-promoting layer, the copper-based layer, and the corrosion-preventing layer.
- the antimicrobial coating is on the internal surface of the catheter assembly including the hub lumen defining the corresponding hub portions of the pair of fluid pathways through the catheter assembly.
- the antimicrobial coating is on the internal surface of the catheter assembly including the extension-leg lumens defining the corresponding extension-leg portions of the pair of fluid pathways through the catheter assembly.
- the antimicrobial coating is on the internal surface of the catheter assembly including an internal surface of each Luer connector, which internal surface defines a corresponding Luer-connector portion of the pair of fluid pathways through the catheter assembly.
- the antimicrobial coating is on the external surface of the catheter assembly including an external surface of each Luer connector.
- the antimicrobial coating is on the external surface of the catheter assembly including abluminal surfaces of the pair of extension legs between at least proximal and distal end portions of each extension leg.
- the antimicrobial coating is on the external surface of the catheter assembly including an abluminal surface of a transcutaneous region of the catheter tube.
- an antimicrobial catheter assembly including, in some embodiments, applying a non-eluting antimicrobial coating to an internal surface, an external surface, or both the internal and external surfaces of one or more components of the catheter assembly; and connecting the components of the catheter assembly to form the catheter assembly.
- the antimicrobial coating is a composite of two or more layers including a copper-based layer between a corrosion-preventing layer and the internal or external surface to which the antimicrobial coating is applied, an adhesion-promoting layer between the copper-based layer and the internal or external surface to which the antimicrobial coating is applied, or a combination thereof.
- applying the antimicrobial coating includes applying the adhesion-promoting layer to the internal or external surface of any component of the one or more components of the catheter assembly.
- the adhesion-promoting layer is applied to the foregoing internal or external surface by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of a metal selected from gold, palladium, and titanium.
- the internal or external surface to which the adhesion-promoting layer is applied includes a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone.
- applying the antimicrobial coating includes applying the copper-based layer to the internal or external surface of any component of the one or more components of the catheter assembly.
- the copper-based layer is applied to the foregoing internal or external surface by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of copper, a copper alloy, or a copper matrix composite.
- the internal or external surface to which the copper-based layer is applied includes a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone or the adhesion-promoting layer.
- applying the antimicrobial coating includes applying the corrosion-preventing layer to the internal or external surface of any component of the one or more components of the catheter assembly.
- the corrosion-preventing layer is applied to the foregoing internal or external surface by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of gold, palladium, or titanium.
- the internal or external surface to which the corrosion-preventing layer is applied includes the copper-based layer.
- connecting the components of the catheter assembly includes inserting a catheter tube into a hub, inserting at least one extension leg into the hub, and inserting the extension leg into at least one Luer connector to form the catheter assembly.
- the catheter assembly has a fluid pathway defined by internal surfaces of a catheter-tube lumen, a hub lumen, and an extension-leg lumen.
- FIG. 1 provides an illustration of a catheter assembly in accordance with some embodiments.
- FIG. 2 provides an illustration of a bifurcated hub of the catheter assembly of FIG. 1 .
- FIG. 3 provides an illustration of a transcutaneous region of a catheter tube of the catheter assembly of FIG. 1 .
- FIG. 4 provides an illustration of a Luer connector of the catheter assembly of FIG. 1 .
- FIG. 5 illustrates a longitudinal cross-section of a catheter tube of a catheter assembly in accordance with some embodiments.
- FIG. 6 illustrates a cross-section of a Luer connector connected to an extension leg of a catheter assembly in accordance with some embodiments.
- FIG. 7 illustrates a cross-section of a Luer connector of a catheter assembly in accordance with some embodiments.
- FIG. 8 illustrates a cross-section of a Luer connector of a catheter assembly in accordance with some embodiments.
- FIG. 9 provides an illustration of a catheter assembly in accordance with some embodiments.
- FIG. 10 provides an illustration of a valved Luer connector of the catheter assembly of FIG. 9 .
- FIG. 11 illustrates a cross-section of a cap over an end portion of the Luer connector of FIG. 10 .
- FIG. 12 provides an illustration of a needleless connector in accordance with some embodiments.
- FIG. 13 provides an illustration of an implantable access port in accordance with some embodiments.
- FIG. 14 A illustrates a longitudinal cross-section of a portion of a medical device including an antimicrobial coating on a surface thereof in accordance with some embodiments.
- FIG. 14 B illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments.
- FIG. 14 C illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments.
- FIG. 14 D illustrates a transverse cross-section of a dual-lumen catheter tube of a catheter assembly including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments.
- FIG. 14 E illustrates a transverse cross-section of a dual-lumen catheter tube of a catheter assembly including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments.
- FIG. 15 A illustrates a longitudinal cross-section of a portion of a medical device including an antimicrobial coating on a surface thereof in accordance with some embodiments.
- FIG. 15 B illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments.
- FIG. 15 C illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments.
- FIG. 16 A illustrates a longitudinal cross-section of a portion of a medical device including an antimicrobial coating on a surface thereof in accordance with some embodiments.
- FIG. 16 B illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments.
- FIG. 16 C illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments.
- FIG. 17 A illustrates a longitudinal cross-section of a portion of a medical device including an antimicrobial coating on a surface thereof in accordance with some embodiments.
- FIG. 17 B illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments.
- FIG. 17 C illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments.
- FIG. 18 is a chart comparing a copper-coated Luer connector to a chlorhexidine-coated Luer connector for a set of microbes.
- FIG. 19 is a chart comparing a copper-coated Luer connector to an uncoated needleless connector with respect to microbial recovery therefrom.
- FIG. 20 is a chart comparing different applications of a water-shed layer to copper-coated Luer connectors.
- proximal portion or a “proximal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near a clinician when the catheter is used on a patient.
- proximal length of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient.
- proximal end of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient.
- the proximal portion, the proximal end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.
- a “distal portion” or a “distal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near or in a patient when the catheter is used on the patient.
- a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient.
- a “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient.
- the distal portion, the distal end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.
- antimicrobial catheters are needed to prevent bacteria colonies that can migrate into the blood.
- antimicrobial catheter assemblies and methods thereof that address the foregoing.
- an antimicrobial catheter assembly including, in some embodiments, a hub, a catheter tube connected to the hub, at least one extension leg connected to the hub, and a non-eluting antimicrobial coating on an internal surface of the catheter assembly, an external surface of the catheter assembly, or both the internal and external surfaces of the catheter assembly.
- the hub includes at least one hub lumen defining a corresponding hub portion of a fluid pathway through the catheter assembly.
- the catheter tube includes at least one catheter-tube lumen defining a corresponding catheter-tube portion of the fluid pathway through the catheter assembly.
- the extension leg includes an extension-leg lumen defining a corresponding extension-leg portion of the fluid pathway through the catheter assembly.
- the antimicrobial coating is a composite of two or more layers.
- the antimicrobial coating includes a copper-based layer between a corrosion-preventing layer and the internal or external surface of the catheter assembly, an adhesion-promoting layer between the copper-based layer and the internal or external surface of the catheter assembly, or a combination thereof.
- FIGS. 1 and 9 depict a catheter assembly (“catheter”) 10 in accordance with some embodiments.
- the catheter 10 includes an elongate catheter tube 12 that extends between proximal and distal ends 12 A, 12 B.
- the catheter tube 12 includes a proximal portion 20 extending distally from the proximal end 12 A and a distal portion 30 extending distally from a distal end of the proximal portion to the distal end 12 B of the catheter tube 12 .
- the catheter tube 12 of the catheter 10 shown in FIG. 1 defines two catheter-tube lumens 14 or a pair of catheter-tube lumens 14 configured for the passage of fluids therein, whereas the catheter tube 12 of the catheter 10 shown in FIG.
- Each catheter-tube lumen 14 of the foregoing catheter-tube lumens 14 is designated as catheter-tube lumen 14 in FIG. 5 , which depicts a longitudinal cross-section of a catheter tube such as the catheter tube 12 of the catheter 10 in either FIG. 1 or FIG. 9 .
- Each catheter-tube lumen 14 of the pair of catheter-tube lumens 14 is designated as catheter-tube lumen 14 in FIGS. 14 D and 14 E , which depict a transverse cross-section of a tubular portion of a two-lumen medical device such as the catheter tube 12 of the catheter 10 of FIG. 1 . More than two catheter-tube lumens 14 such as three catheter-tube lumens are possible in other types of catheters.
- the catheter tube 12 includes a tapered region 24 of the proximal portion 20 extending distally from the hub 16 .
- the tapered region 24 of the catheter tube 12 is the portion of the catheter tube 12 that typically passes through the patient's skin at the insertion site before entering a vein or other vessel of the patient.
- a hub 16 is operably connected to both the proximal end 12 A of the catheter tube 12 and a number of extension legs 18 , each of which is designated as extension leg 18 in FIGS. 1 and 9 .
- the hub 16 provides a number of hub lumens 40 through the hub 16 equal to the number of catheter-tube lumens 14 through the catheter tube 12 and the number of extension legs 18 connected to the hub 16 of the catheter 10 .
- the hub 16 of the catheter 10 shown in FIG. 1 is a bifurcated hub in that it defines two hub lumens 40 or a pair of hub lumens 40 configured for the passage of fluids therein, whereas the hub 16 of the catheter 10 shown in FIG. 9 defines one hub lumen 40 or a single hub lumen 40 configured for the passage of fluids therein.
- Each hub lumen 40 of the pair of hub lumens 40 is designated as hub lumen 40 in FIG. 2 , which depicts the bifurcated hub 16 of the catheter 10 in FIG. 1 , or FIG. 14 D , which depicts a transverse cross-section of a tubular distal-end portion of the bifurcated hub 16 of the catheter 10 of FIG. 1 . More than two hub lumens 40 such as three hub lumens 40 are possible in other types of catheters.
- Each extension leg 18 defines an extension-leg lumen 22 and includes a Luer connector 19 (or another suitable connector) connected to a proximal end thereof to enable a syringe or other device to operably connect with the catheter 10 .
- various components of the catheter 10 define one or more fluid pathways through which fluid can travel through the catheter 10 to infuse fluids including nutrients or drugs into the vein, aspirate blood or other fluids from the vein, or both by way of the catheter 10 .
- the fluid pathway of the catheter 10 is defined by the one or more extension-leg lumens 22 , the one or more hub lumens 40 of the hub 16 , and the one or more catheter-tube lumens 14 of the catheter tube 12 . It is appreciated that additional or other components can contribute to defining a fluid pathway of a catheter in other embodiments, and that other invasive medical devices can include other types of fluid pathways.
- FIG. 2 depicts further details regarding the bifurcated hub 16 of the catheter 10 of FIG. 1 .
- the bifurcated hub 16 defines the pair of hub lumens 40 thereof, which provide fluid communication between the pair of catheter-tube lumens 14 of the catheter tube 12 and the corresponding extension-leg lumens 22 of the pair of extension legs 18 .
- the hub 16 of the catheter 10 of FIG. 9 defines the single hub lumen 40 thereof, which provides fluid communication between the single catheter-tube lumen 14 of the catheter tube 12 and the corresponding extension-leg lumen 22 of the single extension leg 18 .
- the one or more hub lumens 40 , the one or more catheter-tube lumens 14 , and the one or more extension-leg lumens 22 define a substantial portion of the fluid pathway through the catheter 10 .
- the hub 16 can be formed of a plastic such as a thermoset or a thermoplastic, a silicone, one or more metals, one or more ceramics, or glass.
- a plastic from which the hub 16 can be formed includes polyurethane, polycarbonate, polyvinyl chloride (“PVC”), polyethylene, or polypropylene.
- PVC polyvinyl chloride
- ISOPLAST® available from the Lubrizol Corporation, Wickliffe, Ohio, is a thermoplastic polyurethane from which the hub 16 can be formed.
- one or more fluid pathways through the catheter 10 include a substantially non-eluting antimicrobial coating 42 on an internal surface 44 (e.g., a luminal surface) thereof or one or more portions of the internal surface 44 such as the internal surface 44 of the hub lumen 40 , the catheter-tube lumen 14 , the extension-leg lumen 22 , or a combination thereof.
- Any hub lumen 40 of the hub 16 is typically difficult for traditional antimicrobial treatments to reach.
- inclusion of the antimicrobial coating 42 on at least a portion of the internal surface 44 of one or more lumens 40 of the hub 16 improves the ability of the catheter 10 to resist microbial colonization.
- the antimicrobial coating 42 is on an external surface 46 (e.g., an abluminal surface) of the catheter 10 or one or more portions of the external surface 46 such as the external surface 46 of the hub 16 , the catheter tube 12 , the extension leg 18 , or a combination thereof.
- the antimicrobial coating 42 is a composite including at least a copper-based layer configured to provide an antimicrobial effect for inhibiting the establishment or survival of microbes on a coated surface such as the internal surface 44 of the one or more fluid pathways of the catheter 10 or the external surface 46 of one or more components of the catheter 10 .
- any of a variety of surfaces of a medical device such as the catheter 10 of FIG. 1 or FIG. 9 can be coated with the antimicrobial coating 42 , the variety of surfaces being either a part of or independent of the foregoing internal and external surfaces 44 , 46 of the catheter 10 .
- “Substantially non-eluting” means that only a relatively small amount of a metal such as copper is released from the antimicrobial coating 42 into fluids surrounding the antimicrobial coating 42 .
- the antimicrobial coating 42 releases copper particles resulting in a copper concentration of no more than about 1.5 ppm in a fluid such as a bodily fluid in contact with the antimicrobial coating 42 . This release can vary according to various factors including surface composition of the medical device, the type of fluid the antimicrobial coating 42 is exposed to, thickness of one or more layers of the antimicrobial coating 42 , the presence of an overcoat in the antimicrobial coating 42 , etc.
- FIGS. 14 A, 15 A, 16 A, and 17 A each illustrate a longitudinal cross-section of a portion of a medical device such as the catheter 10 including the antimicrobial coating 42 on a surface thereof in accordance with some embodiments.
- the portion of the medical device can be the catheter tube 12 , the hub 16 , or the one or more extension legs 18 of the catheter 10 , and the surface can be the internal surface 44 , the external surface 46 , or both the internal and external surfaces 44 , 46 .
- FIGS. 14 B- 14 E, 15 B, 15 C, 16 B, 16 C, 17 B, and 17 C illustrate transverse cross-sections of a tubular portion of a medical device such as the catheter 10 including the antimicrobial coating 42 in accordance with some embodiments.
- FIGS. 14 B, 14 D, 15 B, 16 B, and 17 B illustrate the antimicrobial coating 42 on the internal or luminal surface 44 of the tubular portion of the medical device shown
- FIGS. 14 C, 14 E, 15 C, 16 C, and 17 C illustrate the antimicrobial coating 42 on the external or abluminal surface 46 of the tubular portion of the medical device shown.
- the antimicrobial coating 42 is a composite of two or more layers.
- the antimicrobial coating 42 includes a copper-based layer 102 .
- the antimicrobial coating 42 includes an overcoat 108 , wherein the copper-based layer 102 is between the surface of the medical device and the overcoat 108 , thereby forming the antimicrobial coating 42 A shown in FIG. 14 A .
- FIG. 14 B illustrates the antimicrobial coating 42 A on the internal or luminal surface 44 of a tubular portion of a single-lumen medical device 100 such as the luminal surface 44 of the catheter tube 12 , the distal end portion of the hub 16 , or the extension leg 18 of the catheter 10 of FIG. 9 , while FIG.
- FIG. 14 C illustrates the antimicrobial coating 42 A on the external or abluminal surface 46 of the foregoing tubular portions of the catheter 10 .
- FIG. 14 D illustrates the antimicrobial coating 42 A on the internal or luminal surfaces 44 of a tubular portion of a dual-lumen medical device 100 such as the luminal surfaces 44 of the catheter tube 12 or the distal end portion of the hub 16 of the catheter 10 of FIG. 1
- FIG. 14 E illustrates the antimicrobial coating 42 A on the external or abluminal surfaces 46 of the foregoing tubular portions of the catheter 10 .
- the antimicrobial coating 42 A can be on both the internal and external surfaces 44 , 46 of the foregoing tubular portions the catheter 10 .
- the copper-based layer 102 is substantially pure copper, a copper alloy, or copper matrix composite.
- the copper alloy includes copper and gold (e.g., rose gold), palladium, zinc (e.g., brass), or tin (e.g., bronze).
- the copper matrix composite includes a copper matrix and tungsten dispersed in the copper matrix.
- the overcoat 108 is configured to prevent tarnishing of the antimicrobial coating 42 by oxidation.
- the overcoat 108 includes Tarniban® manufactured by Technic, Inc., Buffalo, R.I.
- the antimicrobial coating 42 can include an adhesion-promoting layer 104 , wherein the adhesion-promoting layer 104 is between the internal or external surface of the medical device and the copper-based layer 102 , thereby forming the antimicrobial coating 42 B shown in FIG. 15 A .
- the antimicrobial coating 42 B includes the overcoat 108 such that the copper-based layer 102 is between the adhesion-promoting layer 104 and the overcoat 108 .
- FIG. 15 B illustrates the antimicrobial coating 42 B on the internal or luminal surface 44 of a tubular portion of a single-lumen medical device 100 such as the luminal surface 44 of the catheter tube 12 , the distal end portion of the hub 16 , or the extension leg 18 of the catheter 10 of FIG. 9
- FIG. 15 C illustrates the antimicrobial coating 42 B on the external or abluminal surface 46 of the foregoing tubular portions of the catheter 10
- the antimicrobial coating 42 B is not shown on either the internal surfaces 44 or the external surface 46 of a tubular portion of a dual-lumen medical device 100 such as the catheter 10 of FIG.
- the antimicrobial coating 42 B can be applied to the internal surfaces 44 or the external surface 46 of such medical devices resulting in dual-lumen medical devices having transverse cross-sections analogous to those of FIGS. 14 D and 14 E with the antimicrobial coating 42 B. While not shown, the antimicrobial coating 42 B can be on both the internal and external surfaces 44 , 46 of the foregoing tubular portions the catheter 10 .
- the adhesion-promoting layer 104 promotes adhesion of the copper-based layer 102 to the internal surface 44 or the external surface 46 of the medical device, which surface can be a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone.
- the adhesion-promoting layer 104 includes an adhesion-promoting metal including a noble metal (e.g., gold, palladium, silver, iridium, or platinum), a metal having a relatively high resistance to corrosion (e.g., titanium), or an alloy of one of the foregoing metals.
- the antimicrobial coating 42 can include a corrosion-preventing layer 106 , wherein the copper-based layer 102 is between the corrosion-preventing layer 106 and the internal or external surface of the medical device, thereby forming the antimicrobial coating 42 C shown in FIG. 16 A .
- the antimicrobial coating 42 C includes the overcoat 108 such that the corrosion-preventing layer 106 is between the copper-based layer 102 and the overcoat 108 .
- FIG. 16 B illustrates the antimicrobial coating 42 C on the internal or luminal surface 44 of a tubular portion of a single-lumen medical device 100 such as the luminal surface 44 of the catheter tube 12 , the distal end portion of the hub 16 , or the extension leg 18 of the catheter 10 of FIG. 9
- FIG. 16 C illustrates the antimicrobial coating 42 C on the external or abluminal surface 46 of the foregoing tubular portions of the catheter 10
- the antimicrobial coating 42 C is not shown on either the internal surfaces 44 or the external surface 46 of a tubular portion of a dual-lumen medical device 100 such as the catheter 10 of FIG.
- the antimicrobial coating 42 C can be applied to the internal surfaces 44 or the external surface 46 of such medical devices resulting in dual-lumen medical devices having transverse cross-sections analogous to those of FIGS. 14 D and 14 E with the antimicrobial coating 42 C. While not shown, the antimicrobial coating 42 C can be on both the internal and external surfaces 44 , 46 of the foregoing tubular portions the catheter 10 .
- the corrosion-preventing layer 106 prevents corrosion of the copper-based layer 102 .
- the corrosion-preventing layer 106 includes a corrosion-resistant metal including a noble metal (e.g., gold, palladium), a metal having a relatively high resistance to corrosion (e.g., titanium), or an alloy of one of the foregoing metals.
- the copper-based layer 102 can include a copper alloy of copper and gold or palladium. Being as gold and palladium are noble metals, such a copper-based layer 102 is configured to have at least some resistance to corrosion. Therefore, the antimicrobial layer 42 need not have the corrosion-preventing layer 106 when the copper-based layer is a copper alloy of copper and gold or palladium.
- the antimicrobial coating 42 can include both the adhesion-promoting layer 104 and the corrosion-preventing layer 106 , wherein the copper-based layer 102 is between the adhesion-promoting layer 104 and the corrosion-preventing layer 106 , and wherein the adhesion-promoting layer 104 is between the copper-based layer 102 and the internal or external surface of the medical device, thereby forming the antimicrobial coating 42 D shown in FIG. 17 A .
- the antimicrobial coating 42 D includes the overcoat 108 such that the corrosion-preventing layer 106 is between the copper-based layer 102 and the overcoat 108 .
- FIG. 17 B illustrates the antimicrobial coating 42 D on the internal or luminal surface 44 of a tubular portion of a single-lumen medical device 100 such as the luminal surface 44 of the catheter tube 12 , the distal end portion of the hub 16 , or the extension leg 18 of the catheter 10 of FIG. 9
- FIG. 17 C illustrates the antimicrobial coating 42 D on the external or abluminal surface 46 of the foregoing tubular portions of the catheter 10
- the antimicrobial coating 42 D is not shown on either the internal surfaces 44 or the external surface 46 of a tubular portion of a dual-lumen medical device 100 such as the catheter 10 of FIG.
- the antimicrobial coating 42 D can be applied to the internal surfaces 44 or the external surface 46 of such medical devices resulting in dual-lumen medical devices having transverse cross-sections analogous to those of FIGS. 14 D and 14 E with the antimicrobial coating 42 D. While not shown, the antimicrobial coating 42 D can be on both the internal and external surfaces 44 , 46 of the foregoing tubular portions the catheter 10 .
- the antimicrobial coating 42 is configured to not substantially elute metals such as copper into a fluid carried by a medical device such as the catheter 10 or a bodily fluid exposed to the medical device. Indeed, elution of copper from a substantially copper copper-based layer 102 of the antimicrobial coating 42 on an internal, fluid-carrying surface of the Luer connector 19 amounted to about 0.210 ⁇ g when the antimicrobial coating 42 was exposed to a solution of 0.9% saline and 0.157 ⁇ g ethanol for a period of about 24 hours. The amount of copper eluted from the Luer connector 19 represented approximately 0.009% of the total copper content of the antimicrobial coating 42 on the Luer connector, thus evidencing substantial non-elution.
- Each layer of the antimicrobial coating 42 including the adhesion-promoting layer 104 , the copper-based layer 102 , or the corrosion-preventing layer 106 is applied to an internal or external surface of a medical device by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of a metal to produce a substantially uniform, relatively thin layer of the antimicrobial coating 42 .
- Each layer of the antimicrobial coating 42 is sufficiently thin such that flaking or rubbing off a layer of the antimicrobial coating 42 does not occur under normal usage of the medical device including the antimicrobial coating 42 .
- Each layer of the antimicrobial coating 42 can have a thickness less than about 1.0 ⁇ m, including a thickness less than about 0.8 ⁇ m, such as a thickness less than about 0.6 ⁇ m, for example, a thickness less than about 0.5 ⁇ m, which provides a thickness for the antimicrobial coating 42 ranging from about 2.0 ⁇ m for a two-layered antimicrobial coating 42 to about 3.0 ⁇ m for a three-layered antimicrobial coating 42 . That said, each layer of the antimicrobial coating 42 is not limited to less than about 1.0 ⁇ m, and the antimicrobial coating 42 is not limited to a thickness less than about 2.0 ⁇ m to about 3.0 ⁇ m.
- the thickness of the antimicrobial coating 42 can vary in accordance with a number of factors including the desired effective life of the antimicrobial coating 42 , the desired level of antimicrobial efficacy for the antimicrobial coating 42 , indwelling time for the medical device, size limitations of one or more fluid pathways to prevent occlusions in the one or more fluid pathways, or the like.
- antimicrobial coating 42 can be employed on an internal or external surface of a medical device including electroplating, ion beam deposition, or sputtering.
- Different surfaces upon which the antimicrobial coating 42 is applied benefit from certain application techniques.
- metallic surfaces and plastic surfaces including conducting polymers benefit from electroplating the copper-based layer 102 thereon.
- Ceramic surfaces or the like benefit from spray coating the copper-based layer 102 thereon.
- the overcoat 108 of the antimicrobial coating 42 is present, the overcoat 108 is applied by immersing a component of a medical device including one or more other layers of the antimicrobial coating 42 in a solution containing butoxyethanol and butoxyethoxy ethanol for a predetermined time.
- the antimicrobial coating 42 is configured to maintain internal or external surfaces of a medical surface substantially free of microbes through contact killing of such microbes
- other antimicrobial measures can be employed in conjunction with the antimicrobial coating 42 .
- the internal surfaces 44 of the hub lumens 40 of the bifurcated hub 16 can include the antimicrobial coating 42
- at least the internal surface 44 of the catheter-tube lumen 14 of the catheter tube 12 includes a different antimicrobial coating such as that provided by an antimicrobial solution.
- the antimicrobial coating 42 can cooperate with other antimicrobial measures in same or different medical-device locations to provide antimicrobial protection.
- the antimicrobial coating 42 is employed in a variety of medical-device locations including the internal or external surfaces of medical devices such as the catheter 10 of FIG. 1 or FIG. 9 .
- FIGS. 2 - 8 and 10 - 13 give further detail in various non-limiting examples of such the medical-device locations the antimicrobial coating 42 can be employed.
- FIG. 2 depicts the bifurcated hub 16 of the catheter 10 of FIG. 1 , which bifurcated hub provides the pair of hub lumens 40 thereof for fluid communication between the pair of catheter-tube lumens 14 of the catheter tube 12 and the corresponding extension-leg lumens 22 of the pair of extension legs 18 .
- the hub 16 of the catheter 10 of FIG. 9 provides the single hub lumen 40 thereof for fluid communication between the single catheter-tube lumen 14 of the catheter tube 12 and the corresponding extension-leg lumen 22 of the single extension leg 18 .
- the pair of hub lumens 40 or the single hub lumen 40 can include the antimicrobial coating 42 on the internal or luminal surface 44 thereof.
- the external or abluminal surface 46 of the tapered portion 24 of the catheter tube 12 adjacent the bifurcated hub 16 can include the antimicrobial coating 42 thereon.
- the tapered portion 24 is also referred to as the “transcutaneous region” as this portion of the catheter tube 12 extends through a patient's skin and into the patient's vein or other vessel at the insertion site.
- the antimicrobial coating 42 of the external surface of the tapered region 24 is useful to prevent microbial migration from the skin at the insertion site to a remainder of the catheter tube 12 in the patient's vein or other vessel.
- one or more internal surfaces 44 of the tapered portion 24 e.g., luminal surfaces
- FIGS. 4 , 6 , 7 and 8 show that the Luer connector 19 can include the antimicrobial coating 42 on the internal surface 44 in fluid communication with a remainder of the fluid pathway of the catheter 10 , the external surface 46 , or both the internal surface 44 and the external surface 46 of the Luer connector 19 .
- Application of the antimicrobial coating 42 to the connector 19 helps prevent the formation and proliferation of microbes on the internal or external surfaces of the Luer connector including the antimicrobial coating 42 .
- Connectors such as the Luer connector 19 can be especially susceptible to microbial contamination due to relatively extensive physical contact by clinicians or other users of the catheter 10 .
- the antimicrobial coating 42 can be especially suitable on the Luer connector 19 or other portions of medical devices that experience relatively extensive physical contact during a procedure.
- FIG. 8 shows the Luer connector 19 with a copper-containing insert 90 for the internal surface 44 .
- the copper-containing insert 90 along with one or more additional layers of the antimicrobial layer 42 set forth above provides the substantially non-eluting antimicrobial coating 42 configured to provide a contact-killing antimicrobial effect, thereby protecting against the formation or proliferation of microbes therein.
- a variety of medical devices or components thereof can use such copper-containing inserts in one or more locations thereof to provide the copper-based layer 102 of the antimicrobial layer 42 .
- the copper-containing insert 90 can be introduced to a medical or a component thereof (e.g., the Luer connector 19 ) by insert molding with the copper-containing insert 90 .
- Such copper-containing insert can also be included in extruded components as well such the pair of extension legs 18 or the catheter tube 12 of the catheter 10 of FIG. 1 .
- FIG. 6 also shows the internal or luminal surface 58 of the extension leg 18 of the catheter 10 of FIG. 9 , or the internal or luminal surfaces 58 of the pair of extension legs 18 of the catheter 10 of FIG. 1 , can include the antimicrobial coating 42 .
- the antimicrobial coating 42 can prevent the migration of microbes from the internal surface 44 of the Luer connector 19 distally through the extension leg 18 of the catheter 10 to which the Luer connector 19 is connected.
- the external or abluminal surface 46 of the extension leg 18 of the catheter 10 of FIG. 9 or the external of abluminal surfaces of the pair of extension legs 18 of the catheter 10 of FIG.
- the catheter 1 can alternatively or additionally include the antimicrobial coating 42 between at least proximal and distal end portions thereof.
- the antimicrobial coating 42 can be especially susceptible to microbial contamination due to relatively extensive physical contact by clinicians or other users of the catheter 10 .
- FIGS. 9 and 10 show a Luer connector 19 with a flexible valve 60 including the antimicrobial coating 42 on one or more surfaces of the Luer connector 19 .
- the internal surface 44 , the external surface 46 , or both the internal and external surfaces of the Luer connector 19 include the antimicrobial coating 42 .
- the antimicrobial coating 42 is disposed on only a proximal half of the external surface 44 of a body of the Luer connector 19 , though the entirety of the external surface 46 , as well as the internal surface 44 , can be independently coated. Additionally or alternatively, the antimicrobial coating 42 is be disposed on a surface of the valve 60 itself.
- FIG. 11 shows a threaded cap 64 used to removably cover a threaded end of the Luer connector 19 can include the antimicrobial coating 42 .
- both the internal surface 44 and the external surface 46 of the cap 64 can include the antimicrobial coating 42 .
- the cap 64 can help prevent microbial contamination of the Luer connector 19 with which the cap 19 is configured to be threadably engaged.
- caps such as the cap 64 can be especially susceptible to microbial contamination due to relatively extensive physical contact by clinicians or other users of the catheter 10 .
- FIG. 12 shows a needleless connector 110 as another example of a medical device on which the antimicrobial coating 42 can be disposed in order to impart an antimicrobial effect thereto.
- the needleless connector 110 includes the internal surface 44 and the external surface 46 , of which the internal surface 44 includes the antimicrobial coating 42 . That said, the external surface 46 of the needless connector 110 can alternatively or additionally include the antimicrobial coating 42 .
- FIG. 13 shows a copper-containing substance 70 incorporated into a material of a needle-penetrable septum 86 of an access port 80 .
- the copper-containing substance 70 can be incorporated into a forming material for a medical device or a component thereof such as the septum 86 by compounding the forming material with the copper-containing substance 70 and subsequently molding (e.g., injection molding) or extruding the resulting material to provide a copper-containing medical device or a component thereof.
- the septum 86 of the port 80 can be injection molded with silicone or another medically suitable polymer compounded with the copper-containing substance 70 to provide the septum 86 with the copper-containing substance 70 incorporated therein.
- One or more additional layers of the antimicrobial layer 42 can be applied to the septum 86 to provide the septum 86 with the antimicrobial layer 42 , the septum 86 configured to protect a reservoir 84 defined by a body of the port, as well as a fluid pathway through the port 80 together with a port stem, from microbial contamination.
- the septum 86 is but one example of a variety of medical devices and components that can be manufactured in this manner.
- an entirety of the outer surface of the port body 82 includes the antimicrobial coating 42 .
- the embodiments described herein are merely examples of medical devices and components that can benefit from the antimicrobial coating 42 . It is appreciated that a variety of medical devices can include the antimicrobial coating 42 described herein, including peripherally inserted central catheter (“PICCs”), central venous catheters (“CVCs”), hemodialysis catheters, pulmonary artery catheters, arterial catheters, urinary catheters, peritoneal dialysis catheters, enteral feeding tubes, gastrostomy tubes, nasogastric tubes, endotracheal tubes, tracheostomy tubes, umbilical catheters, needleless connectors, midlines catheters, bowel catheters, intermediate dwell catheters, Swan-Ganz catheters, implantable access ports, or other implantable devices.
- PICCs peripherally inserted central catheter
- CVCs central venous catheters
- hemodialysis catheters hemodialysis catheters
- pulmonary artery catheters hemodialysis catheters
- arterial catheters hemodialysis catheters
- urinary catheters
- the antimicrobial coating 42 set forth above is useful in situations where a surface to be treated includes a relatively high durometer plastic, which is often resistant to imbibing typical antimicrobial agents for defeating viruses, bacteria, fungi, etc.
- Areas of a catheter that have traditionally been hard to treat include hubs such as the hub 16 , any hub lumens of the hub 16 , and Luer connectors such as the Luer connector 19 , which often include a high durometer plastics.
- the antimicrobial coating 42 is employed to reduce antimicrobial colonization on fluid-carrying surfaces of medical devices such as luminal surfaces of fluid pathways through catheters or portions thereof (e.g., hubs, Luer connectors), but the antimicrobial coating 42 can also be employed on non-fluid-carrying surfaces of such medical devices.
- the antimicrobial coating 42 serves as an antimicrobial surface, which reduces the likelihood of the establishment or proliferation of microbes on the antimicrobial surface.
- the antimicrobial coating 42 can produce at least a 4-log reduction of microbes present on the antimicrobial surface, even after an extended period of time, such as 31 days or more.
- the antimicrobial coating 42 is substantially non-eluting and serves as a passive barrier to colonization by microbes, including Methicillin-resistant Staphylococcus aureus (“MRSA”), Pseudomonas aeruginosa, Enterobacter aerogenes , Vancomycin-resistant Enterococcus (“VRE”), and yeast such as Candida albicans .
- MRSA Methicillin-resistant Staphylococcus aureus
- VRE Vancomycin-resistant Enterococcus
- yeast such as Candida albicans .
- FIG. 18 depicts a graph 120 showing one example of the efficacy of a copper layer such as the copper-based layer 102 when disposed on a Luer connector such as the Luer connector 19 shown in FIG. 1 .
- FIG. 19 depicts a graph 130 showing one example of the efficacy of a copper layer such as the copper-based layer 102 when disposed on a Luer connector such as the Luer connector 19 shown in FIG. 1 and operably connected to an un-coated needless connector such as the needleless connector 110 shown in FIG. 12 .
- FIG. 20 depicts a graph 140 showing that suitable antimicrobial efficacy is achieved when the optional overcoat 108 is applied to a Luer connector including a copper layer such as the copper-based layer 102 . Additional disclosure regarding the foregoing layers is available in U.S Patent Publication No. 2016/0287758, published Oct. 6, 2016, which is incorporated by reference in its entirety into this application.
- a method of manufacturing an antimicrobial catheter assembly such as the catheter 10 of FIG. 1 or FIG. 9 includes applying the non-eluting antimicrobial coating 42 to the internal surface 44 , the external surface 46 , or both the internal and external surfaces 44 , 46 of one or more components of the catheter 10 ; and connecting the components of the catheter 10 to form the catheter 10 .
- the antimicrobial coating 42 is a composite of two or more layers including the copper-based layer 102 between the corrosion-preventing layer 106 and the internal or external surfaces 44 , 46 to which the antimicrobial coating 42 is applied, the adhesion-promoting layer 104 between the copper-based layer 102 and the internal or external surface 44 , 46 to which the antimicrobial coating 42 is applied, or a combination thereof.
- Applying the antimicrobial coating 42 includes applying the adhesion-promoting layer 104 to the internal or external surface 44 , 46 of any component of the one or more components of the catheter 10 .
- the adhesion-promoting layer 104 is applied to the foregoing internal or external surface 44 , 46 by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of a metal selected from gold, palladium, and titanium.
- the internal or external surface 44 , 46 to which the adhesion-promoting layer 104 is applied includes a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone.
- Applying the antimicrobial coating 42 includes applying the copper-based layer 102 to the internal or external surface 44 , 46 of any component of the one or more components of the catheter 10 .
- the copper-based layer 102 is applied to the foregoing internal or external surface 44 , 46 by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of copper, a copper alloy, or a copper matrix composite.
- the internal or external surface 44 , 46 to which the copper-based layer 102 is applied includes a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone or the adhesion-promoting layer 104 .
- the copper-based layer 102 of the antimicrobial coating 42 can be deposited on the internal surface 44 of the one or more hub lumens 40 of the hub 16 by an electroless deposition process, which can deposit copper on an electrically non-conductive surface without the use of an electric field.
- Electroless deposition includes cleaning a surface upon which deposition is to occur before physically masking portions of any other surfaces upon which deposition should not occur. Next, the cleaned, unmasked surface is prepared by chemically or mechanically etching the surface, for example, by silicon-carbide high-pressure sand blasting.
- a pre-coat layer of copper, nickel, or another suitable metal or material can then be deposited on the etched surface by electroless deposition, which can help improve the efficiency of a subsequent coating such as the copper-based layer 102 .
- the pre-coat layer can be omitted.
- the hub 16 is then placed in a copper chloride bath where an auto-catalytic reaction forms the relatively thin, uniform copper-based layer 102 on the unmasked portions of the hub 16 as a result of an oxidation-reduction reaction.
- FIG. 5 gives one example of this, wherein the catheter tube 12 includes a forming material such as a resin of a thermoplastic or some other suitable polymer, which is mixed, or compounded, with the copper-containing substance 70 before being extruded into the tubular form shown in FIG. 5 .
- Copper-containing substances that can be compounded with the resin include cuprous chloride, cupric chloride, cupric oxide, copper hydroxide, copper oxalate, copper citrate, copper gluconate, copper acetate, copper carbonate, copper sulfate, copper phosphate, other suitable copper salts, finely divided metallic copper, etc.
- the amount of copper-containing substance 70 by mass can vary between about 1% to about 40% by weight, though other percentages can be utilized according to need and desired outcome.
- the copper-containing substance can be mixed as a powder with the resin before being introduced into the extruder, where mixing and melting occurs before extrusion.
- the resultant catheter tube 12 or other extrudate includes a quantity of copper therein sufficient to provide a desired antimicrobial effect to internal or external surfaces.
- Applying the antimicrobial coating 42 includes applying the corrosion-preventing layer 106 to the internal or external surface 44 , 46 of any component of the one or more components of the catheter 10 .
- the corrosion-preventing layer 106 is applied to the foregoing internal or external surface 44 , 46 by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of gold, palladium, or titanium.
- the internal or external surface 44 , 46 to which the corrosion-preventing layer 106 is applied includes the copper-based layer 102 or the like.
- Connecting the components of the catheter 10 includes inserting the catheter tube 12 into the hub 16 , inserting at least one extension leg 18 into the hub 16 , and inserting the extension leg 18 into at least one Luer connector 19 to form the catheter 10 .
- the catheter 10 has a fluid pathway defined by the internal surfaces 44 of a catheter-tube lumen 14 , the hub lumen 40 , and the extension-leg lumen 22 .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
An antimicrobial catheter assembly can include a non-eluting antimicrobial coating on an internal surface, an external surface, or both the internal surface and the external surface of the catheter assembly. The antimicrobial coating can be a composite of three or more layers including a copper-based layer between an outer corrosion-preventing layer of a corrosion-resistant metal and an inner adhesion promoting layer.
Description
- This application is a division of U.S. patent application Ser. No. 16/460,888, filed Jul. 2, 2019, now U.S. Pat. No. 11,730,863, which claims the benefit of priority to U.S. Provisional Application No. 62/693,327, filed Jul. 2, 2018, each of which is incorporated by reference in its entirety into this application.
- Catheters are among the most commonly used medical devices. For example, central venous catheters (“CVCs”) are routinely placed within a patient's vascular system for quickly delivering fluids including nutrients or drugs (e.g., chemotherapeutic agents) or accurately measuring central venous pressure. Often, CVCs are left in place for extended periods of time. However, complications can occur when CVCs are left in place such as catheter-related sepsis (“CRS”), which results when bacteria colonized on such catheters migrate into the blood and cause the inflammatory immune response characteristic of CRS. Replacing such catheters at frequent intervals is one potential solution to CRS, but frequently replacing the catheters often results in replacing sterile catheters that need not to be replaced—and additional catheterization carries with it its own risks. In view of the foregoing, antimicrobial catheters are needed to prevent bacteria colonies that can migrate into the blood. Disclosed herein are antimicrobial catheter assemblies and methods thereof that address the foregoing.
- Disclosed herein is an antimicrobial catheter assembly including, in some embodiments, a hub, a catheter tube connected to the hub, at least one extension leg connected to the hub, and a non-eluting antimicrobial coating on an internal surface of the catheter assembly, an external surface of the catheter assembly, or both the internal and external surfaces of the catheter assembly. The hub includes at least one hub lumen defining a corresponding hub portion of a fluid pathway through the catheter assembly. The catheter tube includes at least one catheter-tube lumen defining a corresponding catheter-tube portion of the fluid pathway through the catheter assembly. The extension leg includes an extension-leg lumen defining a corresponding extension-leg portion of the fluid pathway through the catheter assembly. The antimicrobial coating is a composite of two or more layers. The antimicrobial coating includes a copper-based layer between a corrosion-preventing layer and the internal or external surface of the catheter assembly, an adhesion-promoting layer between the copper-based layer and the internal or external surface of the catheter assembly, or a combination thereof.
- In some embodiments, the adhesion-promoting layer includes an adhesion-promoting metal.
- In some embodiments, the adhesion-promoting metal promotes adhesion of the copper-based layer to a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone.
- In some embodiments, the adhesion-promoting metal is selected from gold, palladium, and titanium.
- In some embodiments, the copper-based layer is substantially pure copper, a copper alloy of copper and gold, palladium, zinc, or tin, or a copper matrix composite of copper and tungsten.
- In some embodiments, the corrosion-preventing layer includes a corrosion-resistant metal selected from gold, palladium, and titanium.
- In some embodiments, the antimicrobial coating includes two layers, the two layers being the adhesion-promoting layer and the copper-based layer.
- In some embodiments, the antimicrobial coating includes two layers, the two layers being the copper-based layer and the corrosion-preventing layer.
- In some embodiments, the antimicrobial coating includes three layers, the three layers being the adhesion-promoting layer, the copper-based layer, and the corrosion-preventing layer.
- In some embodiments, the antimicrobial coating is on the internal surface of the catheter assembly including the hub lumen defining the corresponding hub portion of the fluid pathway through the catheter assembly.
- In some embodiments, the antimicrobial coating is on the internal surface of the catheter assembly including the extension-leg lumen defining the corresponding extension-leg portion of the fluid pathway through the catheter assembly.
- In some embodiments, the antimicrobial coating is on the external surface of the catheter assembly including an abluminal surface of the extension leg between at least proximal and distal end portions of the extension leg.
- In some embodiments, the antimicrobial coating is on the external surface of the catheter assembly including an abluminal surface of a transcutaneous region of the catheter tube.
- In some embodiments, the antimicrobial catheter assembly further includes at least one Luer connector connected to the extension leg. The antimicrobial coating is on the internal surface of the catheter assembly including an internal surface of the Luer connector in fluid communication with the fluid pathway, an external surface of the catheter assembly including an external surface of the Luer connector, or a combination thereof.
- Also disclosed herein is an antimicrobial catheter assembly including, in some embodiments, a bifurcated hub, a catheter tube connected to the hub, a pair of extension legs connected to the hub, a pair of Luer connectors connected to the extension legs, and a non-eluting antimicrobial coating on an internal surface of the catheter assembly, an external surface of the catheter assembly, or both the internal and external surfaces of the catheter assembly. The hub includes a pair of hub lumens defining corresponding hub portions of a pair of fluid pathways through the catheter assembly. The catheter tube includes a pair of catheter-tube lumens defining corresponding catheter-tube portions of the pair of fluid pathways through the catheter assembly. Each extension leg of the pair of extension legs includes an extension-leg lumen defining a corresponding extension-leg portion of the pair of fluid pathways through the catheter assembly. The antimicrobial coating is a composite of two or more layers. The antimicrobial coating includes a copper-based layer between a corrosion-preventing layer and the internal or external surface of the catheter assembly, an adhesion-promoting layer between the copper-based layer and the internal or external surface of the catheter assembly, or a combination thereof.
- In some embodiments, the adhesion-promoting layer promotes adhesion of the copper-based layer to a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone. The adhesion-promoting layer includes a metal selected from gold, palladium, and titanium.
- In some embodiments, the copper-based layer is substantially pure copper, a copper alloy of copper and gold, palladium, zinc, or tin, or a copper matrix composite of copper and tungsten.
- In some embodiments, the corrosion-preventing layer includes a corrosion-resistant metal selected from gold, palladium, and titanium.
- In some embodiments, the antimicrobial coating includes two layers. The two layers are either the adhesion-promoting layer and the copper-based layer or the copper-based layer and the corrosion-preventing layer.
- In some embodiments, the antimicrobial coating includes three layers. The three layers are the adhesion-promoting layer, the copper-based layer, and the corrosion-preventing layer.
- In some embodiments, the antimicrobial coating is on the internal surface of the catheter assembly including the hub lumen defining the corresponding hub portions of the pair of fluid pathways through the catheter assembly.
- In some embodiments, the antimicrobial coating is on the internal surface of the catheter assembly including the extension-leg lumens defining the corresponding extension-leg portions of the pair of fluid pathways through the catheter assembly.
- In some embodiments, the antimicrobial coating is on the internal surface of the catheter assembly including an internal surface of each Luer connector, which internal surface defines a corresponding Luer-connector portion of the pair of fluid pathways through the catheter assembly. Alternatively or additionally, the antimicrobial coating is on the external surface of the catheter assembly including an external surface of each Luer connector.
- In some embodiments, the antimicrobial coating is on the external surface of the catheter assembly including abluminal surfaces of the pair of extension legs between at least proximal and distal end portions of each extension leg.
- In some embodiments, the antimicrobial coating is on the external surface of the catheter assembly including an abluminal surface of a transcutaneous region of the catheter tube.
- Also disclosed herein is a method of manufacturing an antimicrobial catheter assembly including, in some embodiments, applying a non-eluting antimicrobial coating to an internal surface, an external surface, or both the internal and external surfaces of one or more components of the catheter assembly; and connecting the components of the catheter assembly to form the catheter assembly. The antimicrobial coating is a composite of two or more layers including a copper-based layer between a corrosion-preventing layer and the internal or external surface to which the antimicrobial coating is applied, an adhesion-promoting layer between the copper-based layer and the internal or external surface to which the antimicrobial coating is applied, or a combination thereof.
- In some embodiments, applying the antimicrobial coating includes applying the adhesion-promoting layer to the internal or external surface of any component of the one or more components of the catheter assembly. The adhesion-promoting layer is applied to the foregoing internal or external surface by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of a metal selected from gold, palladium, and titanium. The internal or external surface to which the adhesion-promoting layer is applied includes a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone.
- In some embodiments, applying the antimicrobial coating includes applying the copper-based layer to the internal or external surface of any component of the one or more components of the catheter assembly. The copper-based layer is applied to the foregoing internal or external surface by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of copper, a copper alloy, or a copper matrix composite. The internal or external surface to which the copper-based layer is applied includes a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone or the adhesion-promoting layer.
- In some embodiments, applying the antimicrobial coating includes applying the corrosion-preventing layer to the internal or external surface of any component of the one or more components of the catheter assembly. The corrosion-preventing layer is applied to the foregoing internal or external surface by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of gold, palladium, or titanium. The internal or external surface to which the corrosion-preventing layer is applied includes the copper-based layer.
- In some embodiments, connecting the components of the catheter assembly includes inserting a catheter tube into a hub, inserting at least one extension leg into the hub, and inserting the extension leg into at least one Luer connector to form the catheter assembly. The catheter assembly has a fluid pathway defined by internal surfaces of a catheter-tube lumen, a hub lumen, and an extension-leg lumen.
- These and other features of the concepts provided herein will become more apparent to those of skill in the art in view of the accompanying drawings and following description, which describe particular embodiments of such concepts in greater detail.
-
FIG. 1 provides an illustration of a catheter assembly in accordance with some embodiments. -
FIG. 2 provides an illustration of a bifurcated hub of the catheter assembly ofFIG. 1 . -
FIG. 3 provides an illustration of a transcutaneous region of a catheter tube of the catheter assembly ofFIG. 1 . -
FIG. 4 provides an illustration of a Luer connector of the catheter assembly ofFIG. 1 . -
FIG. 5 illustrates a longitudinal cross-section of a catheter tube of a catheter assembly in accordance with some embodiments. -
FIG. 6 illustrates a cross-section of a Luer connector connected to an extension leg of a catheter assembly in accordance with some embodiments. -
FIG. 7 illustrates a cross-section of a Luer connector of a catheter assembly in accordance with some embodiments. -
FIG. 8 illustrates a cross-section of a Luer connector of a catheter assembly in accordance with some embodiments. -
FIG. 9 provides an illustration of a catheter assembly in accordance with some embodiments. -
FIG. 10 provides an illustration of a valved Luer connector of the catheter assembly ofFIG. 9 . -
FIG. 11 illustrates a cross-section of a cap over an end portion of the Luer connector ofFIG. 10 . -
FIG. 12 provides an illustration of a needleless connector in accordance with some embodiments. -
FIG. 13 provides an illustration of an implantable access port in accordance with some embodiments. -
FIG. 14A illustrates a longitudinal cross-section of a portion of a medical device including an antimicrobial coating on a surface thereof in accordance with some embodiments. -
FIG. 14B illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments. -
FIG. 14C illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments. -
FIG. 14D illustrates a transverse cross-section of a dual-lumen catheter tube of a catheter assembly including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments. -
FIG. 14E illustrates a transverse cross-section of a dual-lumen catheter tube of a catheter assembly including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments. -
FIG. 15A illustrates a longitudinal cross-section of a portion of a medical device including an antimicrobial coating on a surface thereof in accordance with some embodiments. -
FIG. 15B illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments. -
FIG. 15C illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments. -
FIG. 16A illustrates a longitudinal cross-section of a portion of a medical device including an antimicrobial coating on a surface thereof in accordance with some embodiments. -
FIG. 16B illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments. -
FIG. 16C illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments. -
FIG. 17A illustrates a longitudinal cross-section of a portion of a medical device including an antimicrobial coating on a surface thereof in accordance with some embodiments. -
FIG. 17B illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on a luminal surface thereof in accordance with some embodiments. -
FIG. 17C illustrates a transverse cross-section of a tubular portion of a medical device including an antimicrobial coating on an abluminal surface thereof in accordance with some embodiments. -
FIG. 18 is a chart comparing a copper-coated Luer connector to a chlorhexidine-coated Luer connector for a set of microbes. -
FIG. 19 is a chart comparing a copper-coated Luer connector to an uncoated needleless connector with respect to microbial recovery therefrom. -
FIG. 20 is a chart comparing different applications of a water-shed layer to copper-coated Luer connectors. - Before some particular embodiments are disclosed in greater detail, it should be understood that the particular embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that a particular embodiment disclosed herein can have features that can be readily separated from the particular embodiment and optionally combined with or substituted for features of any of a number of other embodiments disclosed herein.
- Regarding terms used herein, it should also be understood the terms are for the purpose of describing some particular embodiments, and the terms do not limit the scope of the concepts provided herein. Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a group of features or steps, and do not supply a serial or numerical limitation. For example, “first,” “second,” and “third” features or steps need not necessarily appear in that order, and the particular embodiments including such features or steps need not necessarily be limited to the three features or steps. Labels such as “left,” “right,” “top,” “bottom,” “front,” “back,” and the like are used for convenience and are not intended to imply, for example, any particular fixed location, orientation, or direction. Instead, such labels are used to reflect, for example, relative location, orientation, or directions. Singular forms of “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise.
- With respect to “proximal,” a “proximal portion” or a “proximal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near a clinician when the catheter is used on a patient. Likewise, a “proximal length” of, for example, the catheter includes a length of the catheter intended to be near the clinician when the catheter is used on the patient. A “proximal end” of, for example, the catheter includes an end of the catheter intended to be near the clinician when the catheter is used on the patient. The proximal portion, the proximal end portion, or the proximal length of the catheter can include the proximal end of the catheter; however, the proximal portion, the proximal end portion, or the proximal length of the catheter need not include the proximal end of the catheter. That is, unless context suggests otherwise, the proximal portion, the proximal end portion, or the proximal length of the catheter is not a terminal portion or terminal length of the catheter.
- With respect to “distal,” a “distal portion” or a “distal end portion” of, for example, a catheter disclosed herein includes a portion of the catheter intended to be near or in a patient when the catheter is used on the patient. Likewise, a “distal length” of, for example, the catheter includes a length of the catheter intended to be near or in the patient when the catheter is used on the patient. A “distal end” of, for example, the catheter includes an end of the catheter intended to be near or in the patient when the catheter is used on the patient. The distal portion, the distal end portion, or the distal length of the catheter can include the distal end of the catheter; however, the distal portion, the distal end portion, or the distal length of the catheter need not include the distal end of the catheter. That is, unless context suggests otherwise, the distal portion, the distal end portion, or the distal length of the catheter is not a terminal portion or terminal length of the catheter.
- Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art.
- As set forth above, antimicrobial catheters are needed to prevent bacteria colonies that can migrate into the blood. Disclosed herein are antimicrobial catheter assemblies and methods thereof that address the foregoing.
- For example, an antimicrobial catheter assembly is disclosed including, in some embodiments, a hub, a catheter tube connected to the hub, at least one extension leg connected to the hub, and a non-eluting antimicrobial coating on an internal surface of the catheter assembly, an external surface of the catheter assembly, or both the internal and external surfaces of the catheter assembly. The hub includes at least one hub lumen defining a corresponding hub portion of a fluid pathway through the catheter assembly. The catheter tube includes at least one catheter-tube lumen defining a corresponding catheter-tube portion of the fluid pathway through the catheter assembly. The extension leg includes an extension-leg lumen defining a corresponding extension-leg portion of the fluid pathway through the catheter assembly. The antimicrobial coating is a composite of two or more layers. The antimicrobial coating includes a copper-based layer between a corrosion-preventing layer and the internal or external surface of the catheter assembly, an adhesion-promoting layer between the copper-based layer and the internal or external surface of the catheter assembly, or a combination thereof.
- These and other features will become more apparent to those of skill in the art in view of the accompanying drawings and the following description, which describe such embodiments in greater detail.
- Reference is first made to
FIGS. 1 and 9 , each of which depict a catheter assembly (“catheter”) 10 in accordance with some embodiments. As shown, thecatheter 10 includes anelongate catheter tube 12 that extends between proximal anddistal ends catheter tube 12 includes aproximal portion 20 extending distally from theproximal end 12A and adistal portion 30 extending distally from a distal end of the proximal portion to thedistal end 12B of thecatheter tube 12. Thecatheter tube 12 of thecatheter 10 shown inFIG. 1 defines two catheter-tube lumens 14 or a pair of catheter-tube lumens 14 configured for the passage of fluids therein, whereas thecatheter tube 12 of thecatheter 10 shown inFIG. 9 defines one catheter-tube lumen 14 or a single catheter-tube lumen 14 configured for the passage of fluids therein. Each catheter-tube lumen 14 of the foregoing catheter-tube lumens 14 is designated as catheter-tube lumen 14 inFIG. 5 , which depicts a longitudinal cross-section of a catheter tube such as thecatheter tube 12 of thecatheter 10 in eitherFIG. 1 orFIG. 9 . Each catheter-tube lumen 14 of the pair of catheter-tube lumens 14 is designated as catheter-tube lumen 14 inFIGS. 14D and 14E , which depict a transverse cross-section of a tubular portion of a two-lumen medical device such as thecatheter tube 12 of thecatheter 10 ofFIG. 1 . More than two catheter-tube lumens 14 such as three catheter-tube lumens are possible in other types of catheters. - As shown in
FIG. 3 , thecatheter tube 12 includes a taperedregion 24 of theproximal portion 20 extending distally from thehub 16. The taperedregion 24 of thecatheter tube 12 is the portion of thecatheter tube 12 that typically passes through the patient's skin at the insertion site before entering a vein or other vessel of the patient. - A
hub 16 is operably connected to both theproximal end 12A of thecatheter tube 12 and a number ofextension legs 18, each of which is designated asextension leg 18 inFIGS. 1 and 9 . Thehub 16 provides a number ofhub lumens 40 through thehub 16 equal to the number of catheter-tube lumens 14 through thecatheter tube 12 and the number ofextension legs 18 connected to thehub 16 of thecatheter 10. Thehub 16 of thecatheter 10 shown inFIG. 1 is a bifurcated hub in that it defines twohub lumens 40 or a pair ofhub lumens 40 configured for the passage of fluids therein, whereas thehub 16 of thecatheter 10 shown inFIG. 9 defines onehub lumen 40 or asingle hub lumen 40 configured for the passage of fluids therein. Eachhub lumen 40 of the pair ofhub lumens 40 is designated ashub lumen 40 inFIG. 2 , which depicts thebifurcated hub 16 of thecatheter 10 inFIG. 1 , orFIG. 14D , which depicts a transverse cross-section of a tubular distal-end portion of thebifurcated hub 16 of thecatheter 10 ofFIG. 1 . More than twohub lumens 40 such as threehub lumens 40 are possible in other types of catheters. Eachextension leg 18 defines an extension-leg lumen 22 and includes a Luer connector 19 (or another suitable connector) connected to a proximal end thereof to enable a syringe or other device to operably connect with thecatheter 10. - In light of the above, it is appreciated that various components of the
catheter 10 define one or more fluid pathways through which fluid can travel through thecatheter 10 to infuse fluids including nutrients or drugs into the vein, aspirate blood or other fluids from the vein, or both by way of thecatheter 10. The fluid pathway of thecatheter 10 is defined by the one or more extension-leg lumens 22, the one ormore hub lumens 40 of thehub 16, and the one or more catheter-tube lumens 14 of thecatheter tube 12. It is appreciated that additional or other components can contribute to defining a fluid pathway of a catheter in other embodiments, and that other invasive medical devices can include other types of fluid pathways. -
FIG. 2 depicts further details regarding thebifurcated hub 16 of thecatheter 10 ofFIG. 1 . As shown, thebifurcated hub 16 defines the pair ofhub lumens 40 thereof, which provide fluid communication between the pair of catheter-tube lumens 14 of thecatheter tube 12 and the corresponding extension-leg lumens 22 of the pair ofextension legs 18. Likewise, thehub 16 of thecatheter 10 ofFIG. 9 defines thesingle hub lumen 40 thereof, which provides fluid communication between the single catheter-tube lumen 14 of thecatheter tube 12 and the corresponding extension-leg lumen 22 of thesingle extension leg 18. Together, the one ormore hub lumens 40, the one or more catheter-tube lumens 14, and the one or more extension-leg lumens 22 define a substantial portion of the fluid pathway through thecatheter 10. - Whether the
hub 16 is that of thecatheter 10 ofFIG. 1 orFIG. 9 , thehub 16 can be formed of a plastic such as a thermoset or a thermoplastic, a silicone, one or more metals, one or more ceramics, or glass. A plastic from which thehub 16 can be formed includes polyurethane, polycarbonate, polyvinyl chloride (“PVC”), polyethylene, or polypropylene. For example, ISOPLAST® available from the Lubrizol Corporation, Wickliffe, Ohio, is a thermoplastic polyurethane from which thehub 16 can be formed. - In accordance with some embodiments, one or more fluid pathways through the
catheter 10 include a substantially non-elutingantimicrobial coating 42 on an internal surface 44 (e.g., a luminal surface) thereof or one or more portions of theinternal surface 44 such as theinternal surface 44 of thehub lumen 40, the catheter-tube lumen 14, the extension-leg lumen 22, or a combination thereof. Anyhub lumen 40 of thehub 16 is typically difficult for traditional antimicrobial treatments to reach. As such, inclusion of theantimicrobial coating 42 on at least a portion of theinternal surface 44 of one ormore lumens 40 of thehub 16 improves the ability of thecatheter 10 to resist microbial colonization. Alternatively or additionally to the foregoing, theantimicrobial coating 42 is on an external surface 46 (e.g., an abluminal surface) of thecatheter 10 or one or more portions of theexternal surface 46 such as theexternal surface 46 of thehub 16, thecatheter tube 12, theextension leg 18, or a combination thereof. Theantimicrobial coating 42 is a composite including at least a copper-based layer configured to provide an antimicrobial effect for inhibiting the establishment or survival of microbes on a coated surface such as theinternal surface 44 of the one or more fluid pathways of thecatheter 10 or theexternal surface 46 of one or more components of thecatheter 10. As such, any of a variety of surfaces of a medical device such as thecatheter 10 ofFIG. 1 orFIG. 9 can be coated with theantimicrobial coating 42, the variety of surfaces being either a part of or independent of the foregoing internal andexternal surfaces catheter 10. - “Substantially non-eluting” means that only a relatively small amount of a metal such as copper is released from the
antimicrobial coating 42 into fluids surrounding theantimicrobial coating 42. In some embodiments, for example, theantimicrobial coating 42 releases copper particles resulting in a copper concentration of no more than about 1.5 ppm in a fluid such as a bodily fluid in contact with theantimicrobial coating 42. This release can vary according to various factors including surface composition of the medical device, the type of fluid theantimicrobial coating 42 is exposed to, thickness of one or more layers of theantimicrobial coating 42, the presence of an overcoat in theantimicrobial coating 42, etc. -
FIGS. 14A, 15A, 16A, and 17A each illustrate a longitudinal cross-section of a portion of a medical device such as thecatheter 10 including theantimicrobial coating 42 on a surface thereof in accordance with some embodiments. The portion of the medical device can be thecatheter tube 12, thehub 16, or the one ormore extension legs 18 of thecatheter 10, and the surface can be theinternal surface 44, theexternal surface 46, or both the internal andexternal surfaces FIGS. 14B-14E, 15B, 15C, 16B, 16C, 17B, and 17C illustrate transverse cross-sections of a tubular portion of a medical device such as thecatheter 10 including theantimicrobial coating 42 in accordance with some embodiments.FIGS. 14B, 14D, 15B, 16B, and 17B illustrate theantimicrobial coating 42 on the internal orluminal surface 44 of the tubular portion of the medical device shown, whereasFIGS. 14C, 14E, 15C, 16C, and 17C illustrate theantimicrobial coating 42 on the external orabluminal surface 46 of the tubular portion of the medical device shown. - Again, the
antimicrobial coating 42 is a composite of two or more layers. At a minimum, theantimicrobial coating 42 includes a copper-basedlayer 102. Optionally, theantimicrobial coating 42 includes anovercoat 108, wherein the copper-basedlayer 102 is between the surface of the medical device and theovercoat 108, thereby forming theantimicrobial coating 42A shown inFIG. 14A .FIG. 14B illustrates theantimicrobial coating 42A on the internal orluminal surface 44 of a tubular portion of a single-lumenmedical device 100 such as theluminal surface 44 of thecatheter tube 12, the distal end portion of thehub 16, or theextension leg 18 of thecatheter 10 ofFIG. 9 , whileFIG. 14C illustrates theantimicrobial coating 42A on the external orabluminal surface 46 of the foregoing tubular portions of thecatheter 10.FIG. 14D illustrates theantimicrobial coating 42A on the internal orluminal surfaces 44 of a tubular portion of a dual-lumenmedical device 100 such as the luminal surfaces 44 of thecatheter tube 12 or the distal end portion of thehub 16 of thecatheter 10 ofFIG. 1 , whileFIG. 14E illustrates theantimicrobial coating 42A on the external orabluminal surfaces 46 of the foregoing tubular portions of thecatheter 10. While not shown, theantimicrobial coating 42A can be on both the internal andexternal surfaces catheter 10. - The copper-based
layer 102 is substantially pure copper, a copper alloy, or copper matrix composite. The copper alloy includes copper and gold (e.g., rose gold), palladium, zinc (e.g., brass), or tin (e.g., bronze). The copper matrix composite includes a copper matrix and tungsten dispersed in the copper matrix. - The
overcoat 108 is configured to prevent tarnishing of theantimicrobial coating 42 by oxidation. Theovercoat 108 includes Tarniban® manufactured by Technic, Inc., Providence, R.I. - In addition to the copper-based
layer 102 of theantimicrobial coating 42, theantimicrobial coating 42 can include an adhesion-promotinglayer 104, wherein the adhesion-promotinglayer 104 is between the internal or external surface of the medical device and the copper-basedlayer 102, thereby forming theantimicrobial coating 42B shown inFIG. 15A . Optionally, theantimicrobial coating 42B includes theovercoat 108 such that the copper-basedlayer 102 is between the adhesion-promotinglayer 104 and theovercoat 108.FIG. 15B illustrates theantimicrobial coating 42B on the internal orluminal surface 44 of a tubular portion of a single-lumenmedical device 100 such as theluminal surface 44 of thecatheter tube 12, the distal end portion of thehub 16, or theextension leg 18 of thecatheter 10 ofFIG. 9 , whileFIG. 15C illustrates theantimicrobial coating 42B on the external orabluminal surface 46 of the foregoing tubular portions of thecatheter 10. Theantimicrobial coating 42B is not shown on either theinternal surfaces 44 or theexternal surface 46 of a tubular portion of a dual-lumenmedical device 100 such as thecatheter 10 ofFIG. 1 , but it should be understood theantimicrobial coating 42B can be applied to theinternal surfaces 44 or theexternal surface 46 of such medical devices resulting in dual-lumen medical devices having transverse cross-sections analogous to those ofFIGS. 14D and 14E with theantimicrobial coating 42B. While not shown, theantimicrobial coating 42B can be on both the internal andexternal surfaces catheter 10. - The adhesion-promoting
layer 104 promotes adhesion of the copper-basedlayer 102 to theinternal surface 44 or theexternal surface 46 of the medical device, which surface can be a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone. The adhesion-promotinglayer 104 includes an adhesion-promoting metal including a noble metal (e.g., gold, palladium, silver, iridium, or platinum), a metal having a relatively high resistance to corrosion (e.g., titanium), or an alloy of one of the foregoing metals. - In addition to the copper-based
layer 102 of theantimicrobial coating 42, theantimicrobial coating 42 can include a corrosion-preventinglayer 106, wherein the copper-basedlayer 102 is between the corrosion-preventinglayer 106 and the internal or external surface of the medical device, thereby forming theantimicrobial coating 42C shown inFIG. 16A . Optionally, theantimicrobial coating 42C includes theovercoat 108 such that the corrosion-preventinglayer 106 is between the copper-basedlayer 102 and theovercoat 108.FIG. 16B illustrates theantimicrobial coating 42C on the internal orluminal surface 44 of a tubular portion of a single-lumenmedical device 100 such as theluminal surface 44 of thecatheter tube 12, the distal end portion of thehub 16, or theextension leg 18 of thecatheter 10 ofFIG. 9 , whileFIG. 16C illustrates theantimicrobial coating 42C on the external orabluminal surface 46 of the foregoing tubular portions of thecatheter 10. Theantimicrobial coating 42C is not shown on either theinternal surfaces 44 or theexternal surface 46 of a tubular portion of a dual-lumenmedical device 100 such as thecatheter 10 ofFIG. 1 , but it should be understood theantimicrobial coating 42C can be applied to theinternal surfaces 44 or theexternal surface 46 of such medical devices resulting in dual-lumen medical devices having transverse cross-sections analogous to those ofFIGS. 14D and 14E with theantimicrobial coating 42C. While not shown, theantimicrobial coating 42C can be on both the internal andexternal surfaces catheter 10. - The corrosion-preventing
layer 106 prevents corrosion of the copper-basedlayer 102. The corrosion-preventinglayer 106 includes a corrosion-resistant metal including a noble metal (e.g., gold, palladium), a metal having a relatively high resistance to corrosion (e.g., titanium), or an alloy of one of the foregoing metals. As set forth above, the copper-basedlayer 102 can include a copper alloy of copper and gold or palladium. Being as gold and palladium are noble metals, such a copper-basedlayer 102 is configured to have at least some resistance to corrosion. Therefore, theantimicrobial layer 42 need not have the corrosion-preventinglayer 106 when the copper-based layer is a copper alloy of copper and gold or palladium. - The
antimicrobial coating 42 can include both the adhesion-promotinglayer 104 and the corrosion-preventinglayer 106, wherein the copper-basedlayer 102 is between the adhesion-promotinglayer 104 and the corrosion-preventinglayer 106, and wherein the adhesion-promotinglayer 104 is between the copper-basedlayer 102 and the internal or external surface of the medical device, thereby forming the antimicrobial coating 42D shown inFIG. 17A . Optionally, the antimicrobial coating 42D includes theovercoat 108 such that the corrosion-preventinglayer 106 is between the copper-basedlayer 102 and theovercoat 108.FIG. 17B illustrates the antimicrobial coating 42D on the internal orluminal surface 44 of a tubular portion of a single-lumenmedical device 100 such as theluminal surface 44 of thecatheter tube 12, the distal end portion of thehub 16, or theextension leg 18 of thecatheter 10 ofFIG. 9 , whileFIG. 17C illustrates the antimicrobial coating 42D on the external orabluminal surface 46 of the foregoing tubular portions of thecatheter 10. The antimicrobial coating 42D is not shown on either theinternal surfaces 44 or theexternal surface 46 of a tubular portion of a dual-lumenmedical device 100 such as thecatheter 10 ofFIG. 1 , but it should be understood the antimicrobial coating 42D can be applied to theinternal surfaces 44 or theexternal surface 46 of such medical devices resulting in dual-lumen medical devices having transverse cross-sections analogous to those ofFIGS. 14D and 14E with the antimicrobial coating 42D. While not shown, the antimicrobial coating 42D can be on both the internal andexternal surfaces catheter 10. - The
antimicrobial coating 42 is configured to not substantially elute metals such as copper into a fluid carried by a medical device such as thecatheter 10 or a bodily fluid exposed to the medical device. Indeed, elution of copper from a substantially copper copper-basedlayer 102 of theantimicrobial coating 42 on an internal, fluid-carrying surface of theLuer connector 19 amounted to about 0.210 μg when theantimicrobial coating 42 was exposed to a solution of 0.9% saline and 0.157 μg ethanol for a period of about 24 hours. The amount of copper eluted from theLuer connector 19 represented approximately 0.009% of the total copper content of theantimicrobial coating 42 on the Luer connector, thus evidencing substantial non-elution. - Each layer of the
antimicrobial coating 42 including the adhesion-promotinglayer 104, the copper-basedlayer 102, or the corrosion-preventinglayer 106 is applied to an internal or external surface of a medical device by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition of a metal to produce a substantially uniform, relatively thin layer of theantimicrobial coating 42. Each layer of theantimicrobial coating 42 is sufficiently thin such that flaking or rubbing off a layer of theantimicrobial coating 42 does not occur under normal usage of the medical device including theantimicrobial coating 42. Each layer of theantimicrobial coating 42 can have a thickness less than about 1.0 μm, including a thickness less than about 0.8 μm, such as a thickness less than about 0.6 μm, for example, a thickness less than about 0.5 μm, which provides a thickness for theantimicrobial coating 42 ranging from about 2.0 μm for a two-layeredantimicrobial coating 42 to about 3.0 μm for a three-layeredantimicrobial coating 42. That said, each layer of theantimicrobial coating 42 is not limited to less than about 1.0 μm, and theantimicrobial coating 42 is not limited to a thickness less than about 2.0 μm to about 3.0 μm. Indeed, the thickness of theantimicrobial coating 42 can vary in accordance with a number of factors including the desired effective life of theantimicrobial coating 42, the desired level of antimicrobial efficacy for theantimicrobial coating 42, indwelling time for the medical device, size limitations of one or more fluid pathways to prevent occlusions in the one or more fluid pathways, or the like. - Other application techniques can be employed to deposit one or more layers of the
antimicrobial coating 42 on an internal or external surface of a medical device including electroplating, ion beam deposition, or sputtering. Different surfaces upon which theantimicrobial coating 42 is applied benefit from certain application techniques. For example, metallic surfaces and plastic surfaces including conducting polymers benefit from electroplating the copper-basedlayer 102 thereon. Ceramic surfaces or the like benefit from spray coating the copper-basedlayer 102 thereon. - When the
overcoat 108 of theantimicrobial coating 42 is present, theovercoat 108 is applied by immersing a component of a medical device including one or more other layers of theantimicrobial coating 42 in a solution containing butoxyethanol and butoxyethoxy ethanol for a predetermined time. - While the
antimicrobial coating 42 is configured to maintain internal or external surfaces of a medical surface substantially free of microbes through contact killing of such microbes, other antimicrobial measures can be employed in conjunction with theantimicrobial coating 42. For example, theinternal surfaces 44 of thehub lumens 40 of thebifurcated hub 16 can include theantimicrobial coating 42, while at least theinternal surface 44 of the catheter-tube lumen 14 of thecatheter tube 12 includes a different antimicrobial coating such as that provided by an antimicrobial solution. As such, theantimicrobial coating 42 can cooperate with other antimicrobial measures in same or different medical-device locations to provide antimicrobial protection. - As set forth above, the
antimicrobial coating 42 is employed in a variety of medical-device locations including the internal or external surfaces of medical devices such as thecatheter 10 ofFIG. 1 orFIG. 9 .FIGS. 2-8 and 10-13 give further detail in various non-limiting examples of such the medical-device locations theantimicrobial coating 42 can be employed. - As set forth above,
FIG. 2 depicts thebifurcated hub 16 of thecatheter 10 ofFIG. 1 , which bifurcated hub provides the pair ofhub lumens 40 thereof for fluid communication between the pair of catheter-tube lumens 14 of thecatheter tube 12 and the corresponding extension-leg lumens 22 of the pair ofextension legs 18. Likewise, thehub 16 of thecatheter 10 ofFIG. 9 provides thesingle hub lumen 40 thereof for fluid communication between the single catheter-tube lumen 14 of thecatheter tube 12 and the corresponding extension-leg lumen 22 of thesingle extension leg 18. The pair ofhub lumens 40 or thesingle hub lumen 40 can include theantimicrobial coating 42 on the internal orluminal surface 44 thereof. - In
FIG. 3 , the external orabluminal surface 46 of the taperedportion 24 of thecatheter tube 12 adjacent thebifurcated hub 16 can include theantimicrobial coating 42 thereon. The taperedportion 24 is also referred to as the “transcutaneous region” as this portion of thecatheter tube 12 extends through a patient's skin and into the patient's vein or other vessel at the insertion site. Theantimicrobial coating 42 of the external surface of the taperedregion 24 is useful to prevent microbial migration from the skin at the insertion site to a remainder of thecatheter tube 12 in the patient's vein or other vessel. It is appreciated that one or moreinternal surfaces 44 of the tapered portion 24 (e.g., luminal surfaces) can also include theantimicrobial coating 42—as well as other internal or external surfaces of thecatheter tube 12. -
FIGS. 4, 6, 7 and 8 show that theLuer connector 19 can include theantimicrobial coating 42 on theinternal surface 44 in fluid communication with a remainder of the fluid pathway of thecatheter 10, theexternal surface 46, or both theinternal surface 44 and theexternal surface 46 of theLuer connector 19. Application of theantimicrobial coating 42 to theconnector 19 helps prevent the formation and proliferation of microbes on the internal or external surfaces of the Luer connector including theantimicrobial coating 42. Connectors such as theLuer connector 19 can be especially susceptible to microbial contamination due to relatively extensive physical contact by clinicians or other users of thecatheter 10. As such, theantimicrobial coating 42 can be especially suitable on theLuer connector 19 or other portions of medical devices that experience relatively extensive physical contact during a procedure. - As an alternative to the copper-based
layer 102 of theantimicrobial layer 42,FIG. 8 shows theLuer connector 19 with a copper-containinginsert 90 for theinternal surface 44. The copper-containinginsert 90 along with one or more additional layers of theantimicrobial layer 42 set forth above provides the substantially non-elutingantimicrobial coating 42 configured to provide a contact-killing antimicrobial effect, thereby protecting against the formation or proliferation of microbes therein. A variety of medical devices or components thereof can use such copper-containing inserts in one or more locations thereof to provide the copper-basedlayer 102 of theantimicrobial layer 42. The copper-containinginsert 90 can be introduced to a medical or a component thereof (e.g., the Luer connector 19) by insert molding with the copper-containinginsert 90. Such copper-containing insert can also be included in extruded components as well such the pair ofextension legs 18 or thecatheter tube 12 of thecatheter 10 ofFIG. 1 . - In addition to the
Luer connector 19,FIG. 6 also shows the internal orluminal surface 58 of theextension leg 18 of thecatheter 10 ofFIG. 9 , or the internal orluminal surfaces 58 of the pair ofextension legs 18 of thecatheter 10 ofFIG. 1 , can include theantimicrobial coating 42. Theantimicrobial coating 42 can prevent the migration of microbes from theinternal surface 44 of theLuer connector 19 distally through theextension leg 18 of thecatheter 10 to which theLuer connector 19 is connected. While not shown inFIG. 6 , the external orabluminal surface 46 of theextension leg 18 of thecatheter 10 ofFIG. 9 , or the external of abluminal surfaces of the pair ofextension legs 18 of thecatheter 10 ofFIG. 1 , can alternatively or additionally include theantimicrobial coating 42 between at least proximal and distal end portions thereof. Like connectors such as theLuer connector 19, the external or abluminal surfaces of extension legs like theextension leg 18 can be especially susceptible to microbial contamination due to relatively extensive physical contact by clinicians or other users of thecatheter 10. -
FIGS. 9 and 10 show aLuer connector 19 with aflexible valve 60 including theantimicrobial coating 42 on one or more surfaces of theLuer connector 19. Theinternal surface 44, theexternal surface 46, or both the internal and external surfaces of theLuer connector 19 include theantimicrobial coating 42. As best shown inFIG. 10 , theantimicrobial coating 42 is disposed on only a proximal half of theexternal surface 44 of a body of theLuer connector 19, though the entirety of theexternal surface 46, as well as theinternal surface 44, can be independently coated. Additionally or alternatively, theantimicrobial coating 42 is be disposed on a surface of thevalve 60 itself. -
FIG. 11 shows a threadedcap 64 used to removably cover a threaded end of theLuer connector 19 can include theantimicrobial coating 42. Indeed, both theinternal surface 44 and theexternal surface 46 of thecap 64 can include theantimicrobial coating 42. So configured, thecap 64 can help prevent microbial contamination of theLuer connector 19 with which thecap 19 is configured to be threadably engaged. Like connectors such as theLuer connector 19, caps such as thecap 64 can be especially susceptible to microbial contamination due to relatively extensive physical contact by clinicians or other users of thecatheter 10. -
FIG. 12 shows aneedleless connector 110 as another example of a medical device on which theantimicrobial coating 42 can be disposed in order to impart an antimicrobial effect thereto. As shown, theneedleless connector 110 includes theinternal surface 44 and theexternal surface 46, of which theinternal surface 44 includes theantimicrobial coating 42. That said, theexternal surface 46 of theneedless connector 110 can alternatively or additionally include theantimicrobial coating 42. - As an alternative to the copper-based
layer 102 of theantimicrobial coating 42,FIG. 13 shows a copper-containingsubstance 70 incorporated into a material of a needle-penetrable septum 86 of anaccess port 80. The copper-containingsubstance 70 can be incorporated into a forming material for a medical device or a component thereof such as theseptum 86 by compounding the forming material with the copper-containingsubstance 70 and subsequently molding (e.g., injection molding) or extruding the resulting material to provide a copper-containing medical device or a component thereof. One or more additional layers of theantimicrobial layer 42 set forth above applied to the foregoing medical device or the component thereof provides the substantially non-elutingantimicrobial coating 42 configured to provide a contact-killing antimicrobial effect. For example, theseptum 86 of theport 80 can be injection molded with silicone or another medically suitable polymer compounded with the copper-containingsubstance 70 to provide theseptum 86 with the copper-containingsubstance 70 incorporated therein. One or more additional layers of theantimicrobial layer 42 can be applied to theseptum 86 to provide theseptum 86 with theantimicrobial layer 42, theseptum 86 configured to protect areservoir 84 defined by a body of the port, as well as a fluid pathway through theport 80 together with a port stem, from microbial contamination. Theseptum 86 is but one example of a variety of medical devices and components that can be manufactured in this manner. In some embodiments, an entirety of the outer surface of theport body 82 includes theantimicrobial coating 42. - The embodiments described herein are merely examples of medical devices and components that can benefit from the
antimicrobial coating 42. It is appreciated that a variety of medical devices can include theantimicrobial coating 42 described herein, including peripherally inserted central catheter (“PICCs”), central venous catheters (“CVCs”), hemodialysis catheters, pulmonary artery catheters, arterial catheters, urinary catheters, peritoneal dialysis catheters, enteral feeding tubes, gastrostomy tubes, nasogastric tubes, endotracheal tubes, tracheostomy tubes, umbilical catheters, needleless connectors, midlines catheters, bowel catheters, intermediate dwell catheters, Swan-Ganz catheters, implantable access ports, or other implantable devices. - It is appreciated that the
antimicrobial coating 42 set forth above is useful in situations where a surface to be treated includes a relatively high durometer plastic, which is often resistant to imbibing typical antimicrobial agents for defeating viruses, bacteria, fungi, etc. Areas of a catheter that have traditionally been hard to treat include hubs such as thehub 16, any hub lumens of thehub 16, and Luer connectors such as theLuer connector 19, which often include a high durometer plastics. Theantimicrobial coating 42 is employed to reduce antimicrobial colonization on fluid-carrying surfaces of medical devices such as luminal surfaces of fluid pathways through catheters or portions thereof (e.g., hubs, Luer connectors), but theantimicrobial coating 42 can also be employed on non-fluid-carrying surfaces of such medical devices. - The
antimicrobial coating 42 serves as an antimicrobial surface, which reduces the likelihood of the establishment or proliferation of microbes on the antimicrobial surface. Theantimicrobial coating 42 can produce at least a 4-log reduction of microbes present on the antimicrobial surface, even after an extended period of time, such as 31 days or more. Theantimicrobial coating 42 is substantially non-eluting and serves as a passive barrier to colonization by microbes, including Methicillin-resistant Staphylococcus aureus (“MRSA”), Pseudomonas aeruginosa, Enterobacter aerogenes, Vancomycin-resistant Enterococcus (“VRE”), and yeast such as Candida albicans. Note that a relatively positive electrical charge of theantimicrobial coating 42 on an internal or external surface of a medical device or a component thereof enables serves as a contact-killing surface whereon microbes are immediately killed after contacting the antimicrobial surface. -
FIG. 18 depicts agraph 120 showing one example of the efficacy of a copper layer such as the copper-basedlayer 102 when disposed on a Luer connector such as theLuer connector 19 shown inFIG. 1 .FIG. 19 depicts agraph 130 showing one example of the efficacy of a copper layer such as the copper-basedlayer 102 when disposed on a Luer connector such as theLuer connector 19 shown inFIG. 1 and operably connected to an un-coated needless connector such as theneedleless connector 110 shown inFIG. 12 .FIG. 20 depicts agraph 140 showing that suitable antimicrobial efficacy is achieved when theoptional overcoat 108 is applied to a Luer connector including a copper layer such as the copper-basedlayer 102. Additional disclosure regarding the foregoing layers is available in U.S Patent Publication No. 2016/0287758, published Oct. 6, 2016, which is incorporated by reference in its entirety into this application. - A method of manufacturing an antimicrobial catheter assembly such as the
catheter 10 ofFIG. 1 orFIG. 9 includes applying the non-elutingantimicrobial coating 42 to theinternal surface 44, theexternal surface 46, or both the internal andexternal surfaces catheter 10; and connecting the components of thecatheter 10 to form thecatheter 10. Theantimicrobial coating 42 is a composite of two or more layers including the copper-basedlayer 102 between the corrosion-preventinglayer 106 and the internal orexternal surfaces antimicrobial coating 42 is applied, the adhesion-promotinglayer 104 between the copper-basedlayer 102 and the internal orexternal surface antimicrobial coating 42 is applied, or a combination thereof. - Applying the
antimicrobial coating 42 includes applying the adhesion-promotinglayer 104 to the internal orexternal surface catheter 10. The adhesion-promotinglayer 104 is applied to the foregoing internal orexternal surface external surface layer 104 is applied includes a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone. - Applying the
antimicrobial coating 42 includes applying the copper-basedlayer 102 to the internal orexternal surface catheter 10. The copper-basedlayer 102 is applied to the foregoing internal orexternal surface external surface layer 102 is applied includes a polymer selected from polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone or the adhesion-promotinglayer 104. - With respect to at least the
hub 16, the copper-basedlayer 102 of theantimicrobial coating 42 can be deposited on theinternal surface 44 of the one ormore hub lumens 40 of thehub 16 by an electroless deposition process, which can deposit copper on an electrically non-conductive surface without the use of an electric field. Electroless deposition includes cleaning a surface upon which deposition is to occur before physically masking portions of any other surfaces upon which deposition should not occur. Next, the cleaned, unmasked surface is prepared by chemically or mechanically etching the surface, for example, by silicon-carbide high-pressure sand blasting. - A pre-coat layer of copper, nickel, or another suitable metal or material can then be deposited on the etched surface by electroless deposition, which can help improve the efficiency of a subsequent coating such as the copper-based
layer 102. However, the pre-coat layer can be omitted. Thehub 16 is then placed in a copper chloride bath where an auto-catalytic reaction forms the relatively thin, uniform copper-basedlayer 102 on the unmasked portions of thehub 16 as a result of an oxidation-reduction reaction. - It is appreciated that other modes can be employed to provide copper-based
layer 102 to thehub 16 or another component of thecatheter 10.FIG. 5 gives one example of this, wherein thecatheter tube 12 includes a forming material such as a resin of a thermoplastic or some other suitable polymer, which is mixed, or compounded, with the copper-containingsubstance 70 before being extruded into the tubular form shown inFIG. 5 . Copper-containing substances that can be compounded with the resin include cuprous chloride, cupric chloride, cupric oxide, copper hydroxide, copper oxalate, copper citrate, copper gluconate, copper acetate, copper carbonate, copper sulfate, copper phosphate, other suitable copper salts, finely divided metallic copper, etc. The amount of copper-containingsubstance 70 by mass can vary between about 1% to about 40% by weight, though other percentages can be utilized according to need and desired outcome. The copper-containing substance can be mixed as a powder with the resin before being introduced into the extruder, where mixing and melting occurs before extrusion. Theresultant catheter tube 12 or other extrudate includes a quantity of copper therein sufficient to provide a desired antimicrobial effect to internal or external surfaces. - Applying the
antimicrobial coating 42 includes applying the corrosion-preventinglayer 106 to the internal orexternal surface catheter 10. The corrosion-preventinglayer 106 is applied to the foregoing internal orexternal surface external surface layer 106 is applied includes the copper-basedlayer 102 or the like. - Connecting the components of the
catheter 10 includes inserting thecatheter tube 12 into thehub 16, inserting at least oneextension leg 18 into thehub 16, and inserting theextension leg 18 into at least oneLuer connector 19 to form thecatheter 10. Thecatheter 10 has a fluid pathway defined by theinternal surfaces 44 of a catheter-tube lumen 14, thehub lumen 40, and the extension-leg lumen 22. - While some particular embodiments have been disclosed herein, and while the particular embodiments have been disclosed in some detail, it is not the intention for the particular embodiments to limit the scope of the concepts provided herein. Additional adaptations and/or modifications can appear to those of ordinary skill in the art, and, in broader aspects, these adaptations and/or modifications are encompassed as well. Accordingly, departures may be made from the particular embodiments disclosed herein without departing from the scope of the concepts provided herein.
Claims (7)
1. A method of manufacturing an antimicrobial catheter assembly, comprising:
applying a non-eluting antimicrobial coating to an internal surface, an external surface, or both the internal surface and the external surface of the catheter assembly, the antimicrobial coating being a composite of three or more layers including a copper-based layer between an outer corrosion-preventing layer of a corrosion-resistant metal and an inner adhesion promoting layer.
2. The method according to claim 1 , wherein applying the non-eluting antimicrobial coating includes applying the inner adhesion-promoting layer to the internal surface and/or the external surface of the catheter assembly by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition.
3. The method according to claim 2 , wherein the inner adhesion-promoting layer includes a metal selected from the group consisting of gold, palladium, and titanium, and wherein the internal surface and/or the external surface of the catheter assembly is a polymer selected from the group consisting of polyurethane, polycarbonate, polyethylene, polypropylene, polyvinyl chloride, and silicone.
4. The method according to claim 1 , wherein the outer corrosion-preventing layer of a corrosion-resistant metal includes a metal selected from the group consisting of gold, palladium, and titanium, and wherein applying the non-eluting antimicrobial coating includes applying the outer corrosion-preventing layer to the copper-based layer by physical vapor deposition, chemical vapor deposition, electrodeposition, or electroless deposition.
5. The method according to claim 1 , wherein the copper-based layer is substantially pure copper, a copper alloy of copper and gold, palladium, zinc, or tin, or a copper matrix composite of copper and tungsten.
6. The method according to claim 1 , wherein the antimicrobial catheter assembly comprises a catheter tube, a catheter hub connected to the catheter tube, and an extension leg attached to the catheter hub, and wherein the internal surface and the external surface of the catheter assembly is along one or more of the catheter tube, the catheter hub, and the extension leg.
7. The method according to claim 1 , wherein the antimicrobial catheter assembly comprises a catheter tube, a bifurcated catheter hub connected to the catheter tube, a pair of extension legs attached to the bifurcated catheter hub, and a pair of Luer connectors connected to the pair of extension legs, and wherein the internal surface and the external surface of the catheter assembly is along one or more of the catheter tube, the bifurcated catheter hub, the pair of extension legs, and the pair of Luer connectors.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/230,061 US20230372592A1 (en) | 2018-07-02 | 2023-08-03 | Antimicrobial Catheter Assemblies and Methods Thereof |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862693327P | 2018-07-02 | 2018-07-02 | |
US16/460,888 US11730863B2 (en) | 2018-07-02 | 2019-07-02 | Antimicrobial catheter assemblies and methods thereof |
US18/230,061 US20230372592A1 (en) | 2018-07-02 | 2023-08-03 | Antimicrobial Catheter Assemblies and Methods Thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/460,888 Division US11730863B2 (en) | 2018-07-02 | 2019-07-02 | Antimicrobial catheter assemblies and methods thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230372592A1 true US20230372592A1 (en) | 2023-11-23 |
Family
ID=69054566
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/460,888 Active 2040-10-10 US11730863B2 (en) | 2018-07-02 | 2019-07-02 | Antimicrobial catheter assemblies and methods thereof |
US18/230,061 Pending US20230372592A1 (en) | 2018-07-02 | 2023-08-03 | Antimicrobial Catheter Assemblies and Methods Thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/460,888 Active 2040-10-10 US11730863B2 (en) | 2018-07-02 | 2019-07-02 | Antimicrobial catheter assemblies and methods thereof |
Country Status (5)
Country | Link |
---|---|
US (2) | US11730863B2 (en) |
EP (1) | EP3817785A4 (en) |
JP (1) | JP2021530264A (en) |
CN (1) | CN215915829U (en) |
WO (1) | WO2020010152A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023239993A1 (en) * | 2022-06-09 | 2023-12-14 | Novaflux Inc. | Drug-releasing catheter extender-lengthener and catheter extension tube |
Family Cites Families (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4603152A (en) * | 1982-11-05 | 1986-07-29 | Baxter Travenol Laboratories, Inc. | Antimicrobial compositions |
US4933178A (en) | 1988-10-07 | 1990-06-12 | Biointerface Technologies, Inc. | Metal-based antimicrobial coating |
US5520664A (en) * | 1991-03-01 | 1996-05-28 | Spire Corporation | Catheter having a long-lasting antimicrobial surface treatment |
US6620460B2 (en) | 1992-04-15 | 2003-09-16 | Jet-Lube, Inc. | Methods for using environmentally friendly anti-seize/lubricating systems |
US5536248A (en) * | 1992-05-11 | 1996-07-16 | Arrow Precision Products, Inc. | Method and apparatus for electrosurgically obtaining access to the biliary tree and placing a stent therein |
DE4226810C1 (en) | 1992-08-13 | 1994-01-27 | Theodor Dipl Ing Krall | Hoses and other objects made of plastic for medical use, which are not colonized by germs and processes for their manufacture |
US6287484B1 (en) | 1992-11-12 | 2001-09-11 | Robert Hausslein | Iontophoretic material |
US6333093B1 (en) | 1997-03-17 | 2001-12-25 | Westaim Biomedical Corp. | Anti-microbial coatings having indicator properties and wound dressings |
US6436422B1 (en) | 1998-11-23 | 2002-08-20 | Agion Technologies L.L.C. | Antibiotic hydrophilic polymer coating |
US6585767B1 (en) | 1998-11-23 | 2003-07-01 | Agion Technologies, Inc. | Antimicrobial suturing ring for heart valve |
US6322588B1 (en) | 1999-08-17 | 2001-11-27 | St. Jude Medical, Inc. | Medical devices with metal/polymer composites |
US6368611B1 (en) | 1999-08-31 | 2002-04-09 | Sts Biopolymers, Inc. | Anti-infective covering for percutaneous and vascular access device and coating method |
US6716895B1 (en) | 1999-12-15 | 2004-04-06 | C.R. Bard, Inc. | Polymer compositions containing colloids of silver salts |
EP1328590B1 (en) | 2000-10-11 | 2011-08-03 | Chemetall GmbH | Method for pretreating and/or coating metallic surfaces with a paint-like coating prior to forming and use of substrates coated in this way |
DE10146050B4 (en) | 2001-09-18 | 2007-11-29 | Bio-Gate Ag | Process for the preparation of an antimicrobial adhesive and coating material |
GB0127786D0 (en) | 2001-11-20 | 2002-01-09 | Univ Nottingham | Impregnation of antimicrobial substances |
US7357949B2 (en) | 2001-12-21 | 2008-04-15 | Agion Technologies Inc. | Encapsulated inorganic antimicrobial additive for controlled release |
US7951853B2 (en) | 2002-05-02 | 2011-05-31 | Smart Anti-Microbial Solutions, Llc | Polymer-based antimicrobial agents, methods of making said agents, and products incorporating said agents |
US7829029B2 (en) | 2002-05-29 | 2010-11-09 | NanoVibronix, Inv. | Acoustic add-on device for biofilm prevention in urinary catheter |
US7097850B2 (en) | 2002-06-18 | 2006-08-29 | Surmodics, Inc. | Bioactive agent release coating and controlled humidity method |
JP2006500088A (en) | 2002-08-13 | 2006-01-05 | メドトロニック・インコーポレーテッド | Medical device showing improved adhesion between polymer coating and support |
JP5128757B2 (en) | 2002-09-10 | 2013-01-23 | プロフェソール・ドクトル・ヨーゼフ−ペーター・グッゲンビヒラー・ドクトル・クリストフ・ヒホス・ゲゼルシャフト・ビュルガーリーヒェン・レッヒツ・アンティミクロビアル・アルゲントゥム・テヒノロギース | Manufacturing method of antibacterial plastic products |
DE10243132B4 (en) | 2002-09-17 | 2006-09-14 | Biocer Entwicklungs Gmbh | Anti-infective, biocompatible titanium oxide coatings for implants and methods of making them |
US20040220534A1 (en) | 2003-04-29 | 2004-11-04 | Martens Paul W. | Medical device with antimicrobial layer |
US7147625B2 (en) | 2003-07-01 | 2006-12-12 | Icet, Inc. | Leg bag accessory |
US20050234516A1 (en) | 2004-02-16 | 2005-10-20 | Gueret Jean-Louis H | Treatment kit, composite structure, electric exciter, and cosmetic treatment method |
US9016221B2 (en) | 2004-02-17 | 2015-04-28 | University Of Florida Research Foundation, Inc. | Surface topographies for non-toxic bioadhesion control |
US7645824B2 (en) | 2004-06-24 | 2010-01-12 | Agion Technologies, Inc | Color stable antimicrobial coatings |
CN102783499A (en) | 2004-07-30 | 2012-11-21 | 金伯利-克拉克环球有限公司 | Antimicrobial devices and compositions |
US8361553B2 (en) | 2004-07-30 | 2013-01-29 | Kimberly-Clark Worldwide, Inc. | Methods and compositions for metal nanoparticle treated surfaces |
US9289378B2 (en) | 2004-09-20 | 2016-03-22 | Avent, Inc. | Antimicrobial amorphous compositions |
US20060083710A1 (en) | 2004-10-18 | 2006-04-20 | Joerger Melissa C | Process for making antimicrobial polymer articles |
GB2422348A (en) | 2005-01-25 | 2006-07-26 | Uponor Innovation Ab | Joining metal to plastic with heat activated adhesive |
US20060210700A1 (en) | 2005-03-18 | 2006-09-21 | Lachner Thomas F | Flexible and plastic radiopaque laminate composition |
US7666494B2 (en) | 2005-05-04 | 2010-02-23 | 3M Innovative Properties Company | Microporous article having metallic nanoparticle coating |
US8623446B2 (en) * | 2006-02-25 | 2014-01-07 | Metascape Llc | Ultraviolet activated antimicrobial surfaces |
US20070259427A1 (en) | 2006-03-27 | 2007-11-08 | Storey Daniel M | Modified surfaces for attachment of biological materials |
ATE539773T1 (en) | 2006-04-07 | 2012-01-15 | Bactiguard Ab | NEW ANTIMICROBIAL SUBSTRATES AND THEIR USES |
CN101460201A (en) | 2006-06-05 | 2009-06-17 | 防菌公司 | A polymer matrix, uses thereof and a method of manufacturing the same |
US20080020210A1 (en) | 2006-07-19 | 2008-01-24 | Griffin Patrick J | Metallized multilayered composite |
US8764960B2 (en) | 2006-08-07 | 2014-07-01 | Inktec Co., Ltd. | Manufacturing methods for metal clad laminates |
DE102006041023B4 (en) | 2006-09-01 | 2014-06-12 | Biocer Entwicklungs Gmbh | Structured coatings for implants and process for their preparation |
WO2008031601A1 (en) | 2006-09-13 | 2008-03-20 | Dsm Ip Assets B.V. | Antimicrobial hydrophilic coating comprising metallic silver particles |
US20100074932A1 (en) | 2006-09-22 | 2010-03-25 | Silke Talsma | Antimicrobial compositions containing gallium |
JP2011500216A (en) | 2007-10-17 | 2011-01-06 | プリンストン ユニバーシティー | Functionalized substrate and manufacturing method thereof |
GB2459081A (en) * | 2008-01-31 | 2009-10-14 | Tecvac Ltd | Coated biomedical components |
US8753561B2 (en) | 2008-06-20 | 2014-06-17 | Baxter International Inc. | Methods for processing substrates comprising metallic nanoparticles |
US8178120B2 (en) | 2008-06-20 | 2012-05-15 | Baxter International Inc. | Methods for processing substrates having an antimicrobial coating |
US8277826B2 (en) | 2008-06-25 | 2012-10-02 | Baxter International Inc. | Methods for making antimicrobial resins |
US20090324738A1 (en) | 2008-06-30 | 2009-12-31 | Baxter International Inc. | Methods for making antimicrobial coatings |
DE102008042237B4 (en) | 2008-09-19 | 2010-07-15 | Airbus Deutschland Gmbh | Metallic coating |
EP2358317A1 (en) | 2008-11-24 | 2011-08-24 | Kimberly-Clark Worldwide, Inc. | Antimicrobial laminate constructs |
CN104069546B (en) | 2009-02-25 | 2020-07-03 | 奥索邦德公司 | Anti-infective functionalized surfaces and methods of making same |
US20100227052A1 (en) | 2009-03-09 | 2010-09-09 | Baxter International Inc. | Methods for processing substrates having an antimicrobial coating |
EP2543399A3 (en) | 2009-12-18 | 2013-07-10 | Dentsply IH AB | Medical device for short time use with quickly releasable antibacterial agent |
WO2011156816A2 (en) | 2010-06-11 | 2011-12-15 | Terence Kloss | Compositions comprising polymers coated with metallic layers and methods of manufacture and use thereof |
CN102071411B (en) | 2010-08-19 | 2012-05-30 | 比亚迪股份有限公司 | Plastic product and preparation method thereof |
SE535732C2 (en) | 2010-09-17 | 2012-11-27 | Nanexa Ab | Polymeric product with protective layer that prevents the ingrowth of fungi or other microbial substances |
US9878143B2 (en) | 2010-09-30 | 2018-01-30 | Covidien Lp | Antimicrobial luer adapter |
WO2012064366A2 (en) * | 2010-11-10 | 2012-05-18 | Searete Llc | System, devices, and methods including catheters configured to monitor and inhibit biofilm formation |
EP2458042A1 (en) | 2010-11-24 | 2012-05-30 | SpinPlant GmbH | Sheet material, method for producing the same and device for carrying out the method |
US8579990B2 (en) | 2011-03-30 | 2013-11-12 | Ethicon, Inc. | Tissue repair devices of rapid therapeutic absorbency |
US20120294919A1 (en) | 2011-05-16 | 2012-11-22 | Basf Se | Antimicrobial Silver Silica Composite |
AU2012258633A1 (en) | 2011-05-24 | 2013-11-28 | Agienic, Inc. | Compositions and methods for antimicrobial metal nanoparticles |
IN2014DN11041A (en) | 2012-06-22 | 2015-09-25 | Z Medica Llc | |
US20140154297A1 (en) | 2012-10-30 | 2014-06-05 | Baxter Healthcare S.A. | Antimicrobial substrates and methods for processing the same |
US20150351851A1 (en) | 2013-02-22 | 2015-12-10 | Eastern Maine Healthcare Services | Blood Pressure Cuff Shield Incorporating Antimicrobial Technology |
WO2014138885A1 (en) | 2013-03-12 | 2014-09-18 | Innovotech Inc. | Polymeric coatings having antimicrobial properties |
EP2976095B1 (en) | 2013-03-15 | 2020-12-23 | 3M Innovative Properties Company | Wound healing compositions |
US9675735B2 (en) * | 2013-03-15 | 2017-06-13 | Parasol Medical LLC | Catheters having an antimicrobial treatment |
GB201310985D0 (en) | 2013-06-20 | 2013-08-07 | Univ Singapore | Surface Modification |
WO2015006421A1 (en) | 2013-07-09 | 2015-01-15 | United Technologies Corporation | Metal-encapsulated polymeric article |
KR101621242B1 (en) | 2014-03-17 | 2016-05-16 | (주)비에스써포트 | Medical tubes having copper based compound |
TWI516291B (en) | 2014-04-10 | 2016-01-11 | 勁捷生物科技股份有限公司 | Antimicrobial adhesive |
US9452242B2 (en) * | 2014-06-11 | 2016-09-27 | Silver Bullet Therapeutics, Inc. | Enhancement of antimicrobial silver, silver coatings, or silver platings |
WO2016040529A1 (en) | 2014-09-09 | 2016-03-17 | Iasis Molecular Sciences | Antimicrobial and biologically active polymer composites and related methods, materials and devices |
US9962522B2 (en) * | 2014-10-29 | 2018-05-08 | Professional Plating, Inc. | Braid plating method for torsional stiffness |
CN204446938U (en) * | 2015-01-08 | 2015-07-08 | 山东峰源医用材料有限公司 | Single use multifunctional flushing drainage catheter |
CA2975967A1 (en) | 2015-02-16 | 2016-08-25 | Tecres S.P.A. | Plastic mateiral for devices to be implanted into the human body or for articular spacers |
EP4062868A3 (en) * | 2015-03-30 | 2022-12-21 | C. R. Bard, Inc. | Application of antimicrobial agents to medical devices |
WO2017053882A1 (en) * | 2015-09-25 | 2017-03-30 | C. R. Bard, Inc. | Catheter assembly including monitoring capabilities |
-
2019
- 2019-07-02 CN CN201990000843.8U patent/CN215915829U/en active Active
- 2019-07-02 JP JP2020571546A patent/JP2021530264A/en active Pending
- 2019-07-02 WO PCT/US2019/040414 patent/WO2020010152A1/en unknown
- 2019-07-02 US US16/460,888 patent/US11730863B2/en active Active
- 2019-07-02 EP EP19830837.1A patent/EP3817785A4/en active Pending
-
2023
- 2023-08-03 US US18/230,061 patent/US20230372592A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3817785A4 (en) | 2022-07-20 |
WO2020010152A1 (en) | 2020-01-09 |
US20200000972A1 (en) | 2020-01-02 |
JP2021530264A (en) | 2021-11-11 |
CN215915829U (en) | 2022-03-01 |
US11730863B2 (en) | 2023-08-22 |
EP3817785A1 (en) | 2021-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11759551B2 (en) | Application of antimicrobial agents to medical devices | |
US20230372592A1 (en) | Antimicrobial Catheter Assemblies and Methods Thereof | |
EP2046422B1 (en) | Vascular access device antimicrobial materials and solutions | |
US9352119B2 (en) | Blood control IV catheter with antimicrobial properties | |
US6451003B1 (en) | Method and apparatus for overcoming infection in a tissue pocket surrounding an implanted device | |
US20070135751A1 (en) | Medical devices | |
US10363342B2 (en) | Anti-inflammatory cannula | |
US20220016392A1 (en) | Tube-containing medical devices with bioactive luminal wire | |
Szycher | Medical applications | |
Szycher | Polyurethanes: Medical Applications | |
JPWO2020010152A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |